Stephen D Ginsberg, Phd
Stephen D Ginsberg, Phd
Professor of Neurology

University Hospital of Munich, Munich
Germany

Education

  • 1988 - B.A.      Cornell University, Ithaca, NY, USA
  • 1993 - Ph.D.    Neuroscience, Mount Sinai Medical Center, New York, NY, USA

Training:

  • 1993-1995       Postdoctoral Fellow, Division of Neuropathology, Department of Pathology,  The  Johns  Hopkins  University  School  of  Medicine, Baltimore, MD, USA
  • 1995-1999  Postdoctoral  Fellow,  Center   for   Neurodegenerative   Disease Research, Department of Pathology & Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

 

Profile

 

Research Interest

  • Molecular fingerprint analysis of selective  vulnerability  of  hippocampal, cortical, and cholinergic basal forebrain neurons in human postmortem brain and in animal models of neurodegeneration.
  • Mechanisms underlying neuroplasticity in hippocampal pyramidal neurons and cholinergic basal forebrain neurons in animal models of Alzheimer disease and Down syndrome.
  • Assessment of in vivo therapeutic interventions in animal models  of Alzheimer’s disease and Down syndrome, including caloric restriction (CR) and maternal dietary choline supplementation (MCDS).
  • MicroRNA expression profiling in neurodegenerative disease brain.

 

Professional Activities:

Academic Appointments:

2011- present Associate Professor with Tenure  Departments of Psychiatry, Physiology & Neuroscience, New York University  Langone Medical Center New York, USA
2007-2011 Associate Professor, Departments of Psychiatry, Physiology & Neuroscience, New York University Langone Medical Center New York, USA
2002-2007     Assistant Professor, Department of Physiology & Neuroscience, New York University Langone Medical Center New York, USA
2001-2007  Assistant  Professor,   Department   of   Psychiatry,   New   York University Langone Medical Center New York, USA
2001- present Research Scientist VI, Center for Dementia Research, Nathan Kline Institute Orangeburg, NY, USA
1999-2001 Assistant Professor, Departments of Pediatrics and Neuroscience, Baylor College of Medicine Houston, TX, USA

Other Professional Positions:

2014-present Center for Cognitive Neurology (CCN) New York University Langone Medical Center New York, USA
2013-present Human Microbiome Program (HMP) New York University Langone Medical Center New York, USA
2012-2014 Comprehensive Center for Brain Aging (CCBA) New York University Langone Medical Center New York, USA
2009- present Faculty Associate, Cell and Molecular Biology (CMB) Training Program New York University Langone Medical Center New York, USA
2008-2011 Center of Excellence for Brain Aging (CBA) New York University Langone Medical Center New York, USA
2004-present Faculty Associate Sackler Institute, New York University Langone Medical Center New York, USA
2004-present Faculty Associate, Neurosciences & Physiology Training Program New York University Langone Medical Center New York, USA
2002-present Faculty Associate, Silberstein Institute for Aging and Dementia New York University Langone Medical Center New York, USA
2000-2001 Faculty Associate Huffington Center on Aging, Baylor College of Medicine Houston, TX, USA

Professional Societies:

  • Society for Neuroscience (1991-present)
  • Public Employees Federation (PEF) (2001-present) NYU-Bellevue Psychiatric Society (2003-present)
  • New York Academy of Sciences (NYAS) (2004-present) Science Advisory Board (2007-present)
  • Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) (2012-present)

Editorships:

  • Guest Editor, Neurochemical Research Special Issue “Expression Profiling Within the CNS”, Neurochem. Res., 27:, 2002
  • Guest Editor, Neurochemical Research Special Issue “Expression Profiling Within the CNS II”, Neurochem. Res., 29:, 2004
  • Section  Editor,  Handbook  of  Neurochemistry  and  Molecular  Neurobiology,  3rd Edition, 2007
  • Section Editor, PLoS One (2013-present)
  • Associate Editor, Translational Neuroscience (2009-present) Associate Editor, PLoS One (2010-2013)
  • Associate Editor, Journal of Alzheimer’s Disease (2011-2012)

Editorial Boards:

  • Advances in Geriatrics (2013-present)
  • American Journal of Alzheimer’s Disease and Other Dementias (2004-2007)
  • American Journal of Human Pathology (2013-present)
  • American Journal of Neurodegenerative Disease (2012-present)
  • Archives of Physiology (2013-present)
  • Austin Journal of Genetics and Genomic Research (2013-present)
  • Brain Structure and Function (2010-present) Frontiers in Biological Sciences (2006-present)
  • Frontiers in Neuroanatomy (2008-present)
  • Handbook of Neurochemistry and Molecular Neurobiology (2006-present)
  • Journal of Alzheimer's Disease & Parkinsonism (2011-present)
  • Journal of Chemical Neuroanatomy (2011-present)
  • Journal of Gene Therapy for Genetic Disorders (2014-present)
  • Journal of Geriatrics (2013-present)
  • Journal of Neuroinfectious Diseases (2014-present)
  • Neural Regeneration Research (2012-present)
  • Neuroimmunology and Neuroinflammation (2014-present)
  • Open Longevity Science (2007-present)
  • Scientific World Journal (2011-present)
  • SOJ Psychology (2013-present)

Academic Committees:

  • Chairman, Institutional Animal Care and Use Committee (IACUC), Nathan Kline Institute, Orangeburg, NY (2010-2014)
  • Interim  Chairman,  Institutional  Animal  Care  and  Use  Committee  (IACUC), Nathan Kline Institute, Orangeburg, NY (2007-2009)
  • Institutional Animal Care and Use Committee (IACUC), Nathan Kline Institute, Orangeburg, NY (2005-present)
  • Cell and Molecular Biology (CMB) Training Program, New York University Langone Medical Center, New York, NY (2009-present)
  • Departmental Appointments and Promotions Committee (DAPC), Department of Psychiatry, New York University Langone Medical Center, New York, NY (2008-present)
  • Resident Admissions, Department of Psychiatry, New York University Langone Medical Center, New York, NY (2013-present)
  • Medical Science Training Program (MSTP) Admissions, New York University Langone Medical Center, New York, NY (2005-present)
  • Graduate Admissions, Sackler Institute, New York University Langone Medical Center, New York, NY (2005-present)

Invited Presentations:

  • Cephalon, Inc., West Chester, PA, March, 1997.
  • Department of Neurobiology and Anatomy, University of Rochester School of Medicine, Rochester, NY, December, 1997.
  • Mayo Clinic, Jacksonville, FL, February, 1998.
  • Department  of  Psychiatry,  University  of  Pittsburgh  School  of  Medicine, Pittsburgh, PA, April, 1998.
  • Department  of  Psychiatry,  University  of  Pennsylvania  School  of  Medicine, Philadelphia, PA, June, 1998.
  • Laboratory of Signal Transduction, National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC, August, 1998.
  • Department of Neurosurgery, University of Pennsylvania School of Medicine, Philadelphia, PA, October, 1998.
  • Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, November, 1998.
  • Center  for  Dementia  Research,  Nathan  Kline  Institute,  Orangeburg,  NY, November, 1998.
  • Cognitive Neurology Program, Northwestern University School of Medicine, Chicago, IL, December, 1998.
  • Molecular Dynamics Inc., Sunnyvale, CA, December, 1998.
  • Division  of  Neurology,  Duke  University  School  of  Medicine,  Durham,  NC, January, 1999.
  • Department of Anatomy and Neurobiology, University of Tennessee-Memphis College of Medicine, Memphis, TN, January, 1999.
  • Division  of  Pediatric  Oncology,  Baylor  College  of  Medicine,  Houston,  TX, March, 1999.
  • Division of Neuroscience, Baylor College of Medicine, Houston, TX, September, 1999.
  • Preuss Foundation Meeting, La Jolla, CA, March, 2000.
  • Huffington Center on Aging, Baylor College of Medicine, Houston, TX, January, 2001.
  • Center for Neurodegenerative Disease Research, Emory University School of Medicine, Atlanta, GA, January, 2001.
  • Ambion, Inc., Austin, TX, April, 2001.
  • cDNA Microarray Course, Society for Neuroscience, San Diego, CA, November, 2001.
  • Workshop on use of Nonhuman Primates in Neuroscience Research, Oregon National Primate Research Center, Beaverton, OR, June, 2002.
  • Workshop on Emerging Technologies for the Study of Reproductive Neuroendocrinology, National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, MD, October, 2002.
  • Department of Bioengineering, University of Pennsylvania School of Engineering, Philadelphia, PA, December, 2002.
  • 36th Annual Winter Conference on Brain Research, Snowbird, UT, January, 2003.
  • Taub Alzheimer’s Institute, Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY, February, 2003.
  • Department of Neurology, Mount Sinai School of Medicine, New York, NY, February, 2003.
  • International Congress on Schizophrenia Research (ICOSR), Colorado Springs, CO, March, 2003.
  • Profiling PCR and Beyond, Cambridge Healthtech Institute, Baltimore,  MD, June, 2003.
  • Center for Integrated Genomics, NYU Cancer Institute, New York University School of Medicine, New York, NY, January, 2004.
  • Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA, January, 2004.
  • Invitrogen Corporation, Carlsbad, CA, March, 2004.
  • Department of Psychiatry, New York University School of Medicine, New York, NY, April, 2004.
  • Genomic and Proteomic Sample Preparation, Cambridge Healthtech Institute Boston, MA, April, 2004.
  • Novel Methods in Genetic Exploration of Neurodegenerative Disease,  New York Academy of Sciences, New York, NY, May, 2004.
  • Laser Microdissection and Expression Analysis, Dutch Endo-Neuro-Psycho Meeting, Doorwerth, Netherlands, June, 2004.
  • Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, Leiden, Netherlands, June, 2004.
  • Sackler Institute, New York University School of Medicine, New York, NY, October, 2004.
  • Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY, March, 2005.
  • Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, April, 2005.
  • Department of Neurobiology, University of Chicago, Chicago, IL, April, 2005.
  • Department   of   Pharmacology,   University   of   Connecticut   Health   Center, Farmington, CT, September, 2005.
  • 3rd  Annual  Research  Day,  Department  of  Psychiatry,  New  York  University School of Medicine, New York, NY, September, 2005.
  • Grand Rounds, Department of Psychiatry and Behavioral Sciences, St. Vincent’s Medical Center, New York Medical College, New York, NY, October, 2005.
  • Max-Planck-Unit for Structural Molecular Biology, DESY, Hamburg, Germany, August, 2006.
  • EMBO Practical Course ‘Genome, Transcriptome, and miRNome Analysis of Single Cells’, Miltenyi Biotec, Cologne, Germany, August, 2006.
  • Department of Neuroscience,  Temple University School of Medicine, Philadelphia, PA, January, 2007.
  • Graduate School of Biological Sciences, Mount Sinai School of Medicine, New York, NY, April, 2007.
  • Graduate Program Neuroscience Retreat, New York University, Lake Mohonk, NY, April, 2007.
  • Take Your Child to Work Day, Nathan Kline Institute, Orangeburg, NY, April, 2007.
  • Mountain State and Empire State Collaborative Initiative, New York University, New York, NY, September, 2007.
  • Fourth Muenster Conference on Single Cell Analysis, Westfalische Wilhelms University, Muenster, Germany, November, 2007.
  • Division of Psychiatry Research, Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY, January, 2008.
  • Center for Neural Science, New York University, New York, NY, April, 2008.
  • Alzheimer’s Disease Research Center, Department of Neurology, Washington University School of Medicine, St. Louis, MO, April, 2008.
  • Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY, May, 2008.
  • Grand Rounds, Departments of Neurology/Neurosurgery/Neuroscience, Temple University School of Medicine, Philadelphia, PA, October, 2008.
  • Biomarker Discovery Division, Siemens Molecular Imaging Inc., Culver City, CA, January, 2009.
  • Conte Center Advisory Board Meeting, Department of Psychiatry, New York University Langone Medical Center, New York, NY, December, 2009.
  • Keynote Speaker, 12th Annual Pathology Young Investigator’s Day, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, April, 2010.
  • Summer Undergraduate Research Program (SURP), Department of Psychiatry, New York University Langone Medical Center, Orangeburg, NY, July, 2010.
  • Plenary Speaker, International Conference on Alzheimer’s Disease 2010 (ICAD), Honolulu, HI, July, 2010.
  • Burke Medical Research Institute, Weill Medical College, Cornell University, White Plains, NY, July, 2010.
  • Panelist, Microdissection and microarrays: analyzing selective cell vulnerability, Alzheimer Research Forum (AlzForum) Web Conference, September, 2010.
  • Conte Center Advisory Board Meeting, Department of Psychiatry, New York University Langone Medical Center, New York, NY, March, 2011.
  • Summer Undergraduate Research Program (SURP), Department of Psychiatry, New York University Langone Medical Center, Orangeburg, NY, July, 2011.
  • 45th Annual Winter Conference on Brain Research, Snowbird, UT, January, 2012.
  • NYU Neuroscience Retreat, Mohonk Mountain House, New Paltz, NY, April, 2012.
  • Conte Center Advisory Board Meeting, Department of Psychiatry, New York State Psychiatric Institute, New York, NY, April, 2012.
  • Adams Super Center for Brain Studies, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, June, 2012.
  • Department of Neurobiology and Anatomy, Drexel University College of Medicine, January, 2013.
  • Center for Health Informatics and Bioinformatics (CHIBI), New York University Langone Medical Center, New York, NY, February, 2013.
  • Conte Center Advisory Board Meeting, Department of Psychiatry, New York State Psychiatric Institute, New York, NY, July, 2013.
  • Alzheimer’s Disease Workshop: Alzheimer’s Disease Research from Different Perspectives. Society for Neuroscience Satellite Meeting, San Diego, CA, November, 2013.
  • Margaret M. Cahn Research Award Presentation, Hudson Valley/Rockland/Westchester        Alzheimer’s Association NY Chapter, November, 2013.
  • Department of Biology, SUNY New Paltz, New Paltz, NY, March, 2014.
  • Eli Lilly and Company, New York, NY, March, 2014.
  • Datashare for Brainhack, New York State Psychiatric Institute, New York, NY, October, 2014.

Corporate Activities:

  • 2001-present Co-founder, Rising Tide Biotechnologies, LLC
  • 2007-present Chief Scientific Officer (CSO) Rising Tide Biotechnologies, LLC
  • 2007-present Chief Financial Officer (CFO) Rising Tide Biotechnologies, LLC

Teaching Experience:

  • 1991-1992       Teaching Assistant, Neuroanatomy for Medical Students, Mt. Sinai School of Medicine, 50 contact hours
  • 1995-1998       Lecturer, Neuroanatomy for Neurology Residents, University of Pennsylvania School of Medicine, 25 contact hours
  • 2001    Lecturer, cDNA microarray course, Society for Neuroscience, San Diego, CA, 6 contact hours
  • 2004    Lecturer, Neurobiology of Aging, Department of Psychiatry, New York University School of Medicine, 6 contact hours
  • 2005    Lecturer, Molecular Pharmacology of Receptors, Department of Pharmacology, New York University School of Medicine, 8 contact hours
  • 2006    Lecturer, Molecular Pharmacology of Receptors, Department of Pharmacology, New York University School of Medicine, 8 contact hours
  • 2006    Lecturer, EMBO Practical Course, Miltenyi Biotech, Cologne, Germany, 12 contact hours
  • 2007    Lecturer, Molecular Pharmacology of Receptors, Department of Pharmacology, New York University School of Medicine, 8 contact hours
  • 2008    Lecturer, Molecular Pharmacology of Receptors, Department of Pharmacology, New York University Langone Medical Center, 8 contact hours
  • 2009    Lecturer, Molecular Pharmacology of Receptors, Department of Pharmacology, New York University Langone Medical Center, 8 contact hours
  • 2010    Lecturer, Molecular Pharmacology of Receptors, Department of Pharmacology, New York University Langone Medical Center, 8 contact hours
  • 2011    Lecturer, Molecular Pharmacology of Receptors, Department of Pharmacology, New York University Langone Medical Center, 8 contact hours
  • 2011    Lecturer, Neuroscience Course in Disorders, Department of Physiology & Neuroscience, New York University Langone Medical Center, 2 contact hours
  • 2012    Lecturer, Molecular Pharmacology of Receptors, Department of Pharmacology, New York University Langone Medical Center, 8 contact hours
  • 2013    Program Consultant, Nyack High School Science Research Program, Nyack High School, Nyack, NY, 2 contact hours
  • 2013    Program Respondent, BIOL 161, Cell Biology & Genetics I: Biotechnology and Society, Macalester College, St. Paul, MN, 2 contact hours
  • 2013    Lecturer, Neuroscience Course in Disorders, Department of Physiology & Neuroscience, New York University Langone Medical Center, 2 contact hours
  • 2014    Program Consultant, Nyack High School Science Research Program, Nyack High School, Nyack, NY, 2 contact hours
  • 2014    Lecturer, Neuroscience Course in Disorders, Department of Physiology & Neuroscience, New York University Langone Medical Center, 2 contact hours

Honors and Awards

Publications

Original Peer Reviewed Articles:

  • Ginsberg, S.D., Hof, P.R., Young, W.G., and Morrison, J.H.: Noradrenergic innervation of the hypothalamus of rhesus monkeys: distribution of dopamine-ß- hydroxylase-immunoreactive fibers and a quantitative analysis of varicosities in the paraventricular nucleus. J. Comp. Neurol., 327: 597-611, 1993. PMID: 8440783.
  • Ginsberg, S.D., Hof, P.R., McKinney, W.T., and Morrison, J.H.: Quantitative analysis of tuberoinfundibular tyrosine hydroxylase- and corticotropin-releasing factor-immunoreactive neurons in monkeys raised with differential rearing conditions. Exp. Neurol., 120: 95-105, 1993. PMID: 8097476.
  • Ginsberg, S.D., Hof, P.R., McKinney, W.T., and Morrison, J.H.: The noradrenergic innervation density of the monkey paraventricular nucleus is not altered by early social deprivation. Neurosci. Lett., 158: 130-134, 1993. PMID: 8233084.
  • Siegel, S.J., Ginsberg, S.D., Hof, P.R., Foote, S.L, Young, W.G., Kraemer, G.W., McKinney, W.T., and Morrison, J.H.: Effects of social  deprivation  on  primate  dentate gyrus granule cells. Brain Res., 619: 299-305, 1993. PMID: 8374785.
  • Ginsberg, S.D., Hof, P.R., Young, W.G., and Morrison, J.H.: Noradrenergic innervation of vasopressin- and oxytocin-containing neurons in the hypothalamic paraventricular nucleus of the macaque monkey: quantitative analysis using double- label immunohistochemistry and confocal laser microscopy. J. Comp. Neurol., 341: 476- 491, 1994. PMID: 8201025.
  • Ginsberg, S.D., Price, D.L., Blackstone, C.D., Huganir, R.L., and Martin, L.J.: Non-NMDA glutamate receptors are present throughout the primate hypothalamus. J. Comp. Neurol., 353: 539-552, 1995. PMID: 7759614.
  • Ginsberg, S.D., Price, D.L., Blackstone, C.D., Huganir, R.L., and Martin,  L.J.: GluR3 is the major AMPA glutamate receptor of oxytocinergic magnocellular neurons and is localized at synapses. Neuroscience, 65: 563-575, 1995. PMID: 7777169.
  • Thinakaran, G., Kitt, C.A., Roskams, A.J.I., Slunt, H.H., Masliah, E., von Koch, C., Ginsberg, S.D., Ronnett, G.V., Reed, R.R., Price, D.L., and Sisodia, S.S.: Distribution of an APP homologue, APLP2, in the mouse olfactory system: a potential role for APLP2 in axogenesis. J. Neurosci., 15: 6314-6326, 1995. PMID: 7472397.
  • Ginsberg, S.D., Martin, L.J., and Rothstein, J.D.: Regional deafferentation down regulates subtypes of glutamate transporter proteins. J. Neurochem., 65: 2800-2803, 1995. PMID: 7595581.
  • Ginsberg, S.D., Rothstein, J.D., Price, D.L., and Martin, L.J.: Fimbria-fornix transections selectively down regulate subtypes of glutamate transporter  and glutamate receptor proteins in septum and hippocampus. J. Neurochem., 67: 1208-1216, 1996. PMID: 8752128.
  • Ginsberg, S.D., Crino, P.B., Lee, V.M-Y., Eberwine, J.H., and Trojanowski, J.Q.: Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann. Neurol., 41: 200-209, 1997. PMID: 9029069.
  • Crino, P., Khodakhah, K., Becker, K., Ginsberg, S., Hemby, S., and Eberwine, J.H: Presence and phosphorylation of transcription factors in developing dendrites. Proc. Natl. Acad. Sci. USA, 95: 2313-2318, 1998. PMID: 9482882.
  • Ginsberg, S.D., and Martin, L.J.: Ultrastructural analysis of the progression of neurodegeneration in the septum following fimbria-fornix transection. Neuroscience, 86: 1259-1272, 1998. PMID: 9697131.
  • Ginsberg, S.D., Galvin, J.E, Chiu, T-S., Lee, V.M-Y., Masliah, E.,  and Trojanowski, J.Q.: RNA sequestration to pathological lesions of neurodegenerative disorders. Acta Neuropathol., 96: 487-494, 1998. PMID: 9829812.
  • Martin, L.J., Portera-Cailliau, C., Ginsberg, S.D., and Al-Abdulla, N.A.: Animal models and degenerative disorders of the human brain. Lab Animal, 27: 18-25, 1998.
  • Ginsberg, S.D., Portera-Cailliau, C., and Martin, L.J.: Fimbria-fornix transection and excitotoxicity produce similar neurodegeneration in septum. Neuroscience, 88: 1059-1071, 1999. PMID: 10336121.
  • Ginsberg, S.D., Crino, P.B., Hemby, S.E., Weingarten, J.A., Lee, V.M-Y., Eberwine, J.H., and Trojanowski, J.Q.: Predominance of neuronal mRNAs in individual Alzheimer’s disease senile plaques. Ann. Neurol., 45: 174-181, 1999. PMID: 9989619.
  • Ginsberg, S.D., Galvin, J.E, Lee, V.M-Y., Rorke, L.B., Dickson, D.W., Wolfe, J.H., Jones, M.Z., and Trojanowski, J.Q.: Accumulation of intracellular amyloid-ß peptide (Aß 1-40) in mucopolysaccharidosis brains. J. Neuropathol. Exp. Neurol., 58: 815-824, 1999. PMID: 10446806.
  • Ginsberg, S.D., Hemby, S.E., Lee, V.M-Y., Eberwine, J.H., and Trojanowski, J.Q.: Expression profile of transcripts in Alzheimer’s disease neurofibrillary tangle-bearing CA1 neurons identifies new potential mediators of neurodegeneration. Ann. Neurol., 48: 77-87, 2000. PMID: 10894219.
  • Ginsberg, S.D., and Martin, L.J.: Axonal transection in adult rat brain induces transsynaptic apoptosis and persistent atrophy of target neurons. J. Neurotrauma, 19: 99-109, 2002. PMID: 11852982.
  • Hemby, S.E., Ginsberg, S.D., Brunk, B., Arnold, S.E., Trojanowski, J.Q., and Eberwine, J.H.: Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch. Gen. Psychiat., 59: 631-640, 2002. PMID: 12090816.
  • Ginsberg, S.D., and Che, S.: RNA amplification in brain tissues. Neurochem. Res., 27: 981-992, 2002. PMID: 12462399.
  • Mufson, E.J., Counts, S.E., and Ginsberg, S.D.: Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer’s disease. Neurochem. Res., 27: 1035- 1048, 2002. PMID: 12462403.
  • King, S.R., Manna, P.R., Ishii, T., Syapin, P.J., Ginsberg, S.D., Wilson, K., Walsh, L.P., Parker, K.L., Stocco, D.M., Smith, R.G., and Lamb, D.J.: An essential component in steroid synthesis, the steroidogenic acute regulatory protein is expressed in discrete regions of the brain. J. Neurosci., 22: 10613-10620, 2002. PMID: 12486153.
  • Hemby, S.E., Trojanowski, J.Q., and Ginsberg, S.D.: Neuron specific age related decreases in dopamine receptor subtype mRNAs. J. Comp. Neurol., 456: 176-83, 2003. PMID: 12509874.
  • Counts, S.E., Perez, S.E., Ginsberg, S.D., de Lacalle, S., and Mufson, E.J.: Galanin plasticity and Alzheimer’s disease. Mol. Interv., 3: 137-156, 2003. PMID: 14993421.
  • Mufson, E.J., Ginsberg, S.D., Ikonomovic, M.D., and DeKosky, S.T.: Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J. Chem. Neuroanat., 26: 233-242, 2003. PMID: 14729126.
  • Che, S., and Ginsberg, S.D.: Amplification of transcripts using terminal continuation. Lab. Invest., 84: 131-137, 2004. PMID: 14647400.
  • Ginsberg, S.D., Elarova, I., Ruben, M., Tan, F., Counts, S.E., Eberwine, J.H., Trojanowski, J.Q., Hemby, S.E., Mufson, E.J., and Che, S.: Single cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders: Neurochem. Res., 29:1053-1064, 2004.
  • Ginsberg, S.D., and Che, S.: Combined histochemical staining, RNA amplification, regional, and single cell analysis within the hippocampus. Lab. Invest., 84:952-962, 2004. PMID: 15107803.
  • King, S.R., Ginsberg, S.D., Ishii, T., Smith, R.G., Parker, K.L., and Lamb, D.J.: The steroidogenic acute regulatory (StAR) protein is expressed in steroidogenic cells of the day-old (P1) brain. Endocrinology, 145:4775-4780, 2004. PMID: 15205373.
  • Counts, S.E., Nadeem, M., Wuu, J., Ginsberg, S.D., Saragovi, H.U., and Mufson, E.J.: Reduction of cortical trkA but not p75NTR NGF receptor protein levels in early stage Alzheimer’s disease. Ann. Neurol., 56:520-531, 2004. PMID: 15455399.
  • Galvin, J.E., and Ginsberg, S.D.: Expression profiling and pharmacotherapeutic development in the central nervous system. Alzheimer Dis. Assoc. Disord., 18:264-269, 2004. PMID: 15592143.
  • Ginsberg, S.D., and Che, S.: Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons. J. Comp. Neurol., 487:107-118, 2005. PMID: 15861457.
  • McClain, K.L., Cai, Y-H., Hicks, J., Peterson, L.E., Yan, X-T., Che, S., and Ginsberg, S.D.: Expression profiling using human tissues in combination with RNA amplification and microarray analysis: assessment of Langerhans cell histiocytosis. Amino Acids, 28:279-280, 2005. PMID: 15791395.
  • Counts, S.E., Chen, E-Y., Ginsberg, S.D., Kordower, J.H., and Mufson, E.J.: RNA amplification of bromodeoxyuridine labeled newborn neurons in the monkey hippocampus. J. Neurosci. Meth., 144:197-201, 2005. PMID: 15910978.
  • Ginsberg, S.D.: Glutamatergic neurotransmission expression profiling in the mouse hippocampus after perforant-path transection. Am. J. Geriatr. Psychiatry 13: 1052-1061, 2005. PMID: 16319297.
  • Ginsberg, S.D.: RNA amplification strategies for small sample populations. Methods, 37: 229-237, 2005. PMID: 16308152.
  • Galvin, J.E., and Ginsberg, S.D.: Expression profiling in the aging brain: a perspective. Ageing Res. Rev., 4: 529-547, 2005. PMID: 16249125.
  • Counts, S.E., Chen, E-Y., Che, S., Ikonomovic, M.D., Wuu, J., Ginsberg, S.D., DeKosky, S.T, and Mufson, E.J.: Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer’s disease. Dement. Geriatr. Cogn. Disord., 21: 205-214, 2006. PMID: 16410678.
  • Ginsberg, S.D., Che, S., Counts, S.E., and Mufson, E.J.: Shift in the ratio of 3- repeat tau and 4-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer’s disease. J. Neurochem., 96: 1401-1408, 2006. PMID: 16478530.
  • Ginsberg, S.D., Che, S., Wuu, J., Counts, S.E., and Mufson, E.J.: Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer’s disease. J. Neurochem., 97: 475-487, 2006. PMID: 16539663.
  • King, S.R., Smith, A.G.A., Alpy, F., Tomasetto, C., Ginsberg, S.D., and Lamb, D.J.: Characterization of the putative cholesterol transport protein MLN64 in the brain. Neuroscience, 139: 1031-1038, 2006. PMID: 16549269.
  • Ginsberg, S.D., Che, S., Counts, S.E., and Mufson, E.J.: Single cell gene expression profiling in Alzheimer’s disease. NeuroRx, 3: 302-318,  2006.  PMID: 16815214.
  • Ginsberg, S.D., and Mirnics, K.: Functional genomics methodologies. Prog. Brain Res., 158: 15-40, 2006. PMID: 17027690.
  • Mufson, E.J., Counts, S.E., Che, S., and Ginsberg, S.D.: Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative  disease. Prog. Brain Res., 158: 197-223, 2006. PMID: 17027698.
  • Mufson, E.J., Counts, S.E., Fahnestock, M., and Ginsberg, S.D.: Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Curr. Alzheimer Res., 4: 340-350, 2007. PMID: 17908035.
  • Counts, S.E., He, B., Che, S., Ikonomovic, M.D., DeKosky, S.T, Ginsberg, S.D., and Mufson, E.J.: a7 Nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Arch. Neurol., 64: 1771-1776, 2007. PMID: 18071042.
  • Counts, S.E., He, B., Che, S., Ginsberg, S.D., Mufson, E.J.: Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer’s disease. Neurodegenerative Dis., 5: 228-231, 2008. PMID: 18322398. PMCID: PMC2826456.
  • Ginsberg, S.D.: Transcriptional profiling of small samples in the central nervous system. Methods Mol. Biol., 439: 147-158, 2008. PMID: 18370101. PMCID: PMC2648843.
  • Levine, S., Saltzman, A., and Ginsberg, S.D.: Different inflammatory reactions to vitamin D(3) among the lateral, third and fourth ventricular choroid plexuses of the rat. Exp. Mol. Pathol., 85: 117-121, 2008. PMID: 18675267.
  • Mufson, E.J., Counts, S.E., Perez, S., and Ginsberg, S.D.: Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications. Expert Rev. Neurother., 8: 1703-1718, 2008. PMID: 18986241. PMCID: PMC2631573.
  • Alldred, M.J., Che, S., and Ginsberg, S.D.: Terminal continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain. Int. J. Mol. Sci., 9: 2091-2104, 2008. PMID: 19165351. PMCID: PMC2629436.
  • Chen, Y., Dyakin, V.V., Branch, C.A., Ardekani, B., Yang, D., Guilfoyle, D.N., Peterson, J., Peterhoff, C., Ginsberg, S.D., Cataldo, A.M., and Nixon, R.A.: In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model. Neurobiol. Aging, 30: 1453-1465, 2009. PMID: 18180075. PMCID: PMC2771203.
  • Altar, C.A., Vawter, M., and Ginsberg, S.D.: Target identification for CNS diseases by transcriptional profiling. Neuropsychopharmacology, 34: 18-54, 2009. PMID: 18923405. PMCID: PMC2675576.
  • Alldred, M.J., Che, S., and Ginsberg, S.D.: Terminal continuation (TC) RNA amplification without second strand synthesis. J. Neurosci. Meth., 177: 381-385, 2009. PMID: 19026688. PMCID: PMC2659495.
  • Levine, S., Saltzman, A., Levy, E., and Ginsberg, S.D.: Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease. Exp. Mol. Pathol., 86: 18-22, 2009. PMID: 19041304. PMCID: PMC2659493.
  • Ikonomovic, M.D., Wecker, L., Abrahamson, E.E., Wuu, J., Counts, S.E., Ginsberg, S.D., Mufson, E.J., and DeKosky, S.T.: Cortical α7 nicotinic acetylcholine receptor and β-amyloid levels in early Alzheimer's disease. Arch. Neurol., 66: 646-651, 2009. PMID: 19433665. PMCID: PMC2841566.
  • Peng, S., Garzon, D.J., Marchese, M., Klein, W., Ginsberg, S.D., Francis, B., Mount, H.T.J., Mufson, E.J., Salehi, A., and Fahnestock, M.: Decreased brain-derived neurotrophic factor depends upon amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J. Neurosci., 29: 9321-9329, 2009. PMID: 19625522.
  • Choi, J.H.K., Berger, J.D., Mazzella, M.J., Morales-Corraliza, J., Nixon, R.A., Ginsberg, S.D., Levy, E., and Mathews, P.M.: Age-dependent dysregulation of brain amyloid precursor protein in  the Ts65Dn Down syndrome  mouse model. J. Neurochem., 110: 1818-1827, 2009. PMID: 19619138. PMCID: PMC2744432.
  • Counts, S.E., He, B., Che, S., Ginsberg, S.D., and Mufson, E.J.: Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer’s disease. J. Alzheimers Dis., 18: 885-896, 2009. PMID: 19749437. PMCID: PMC2884383.
  • Jiang, Y., Mullaney, K.A., Peterhoff, C.M., Che, S., Schmidt, S.D., Boyer-Boiteau, A., Ginsberg, S.D., Cataldo, A.M., Mathews, P.M., and Nixon, R.A.: Alzheimer’s- related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc. Natl. Acad. Sci. USA, 107: 1630-1635, 2010. PMID: 20080541. PMCID: PMC2824382.
  • Ginsberg, S.D.: Alterations in discrete glutamate receptor subunits in adult mouse dentate gyrus granule cells following perforant path transection. Anal. Bioanal. Chem., 397: 3349-3358, 2010. PMID: 20577723. PMCID: PMC3149099.
  • Levine, S., Saltzman, A., and Ginsberg, S.D.: Mitotic figures in the median eminence of the hypothalamus. Neurochem. Res., 35: 1743-1746, 2010. PMID: 20680457. PMCID: PMC3148030.
  • Haskew-Layton, R.E., Payappilly, J.B., Smirnova, N.A., Ma, T.C., Chan, K.K., Murphy, T.H., Guo, H., Langley, B., Sultana, R., Butterfield, D.A., Santagata, S., Alldred, M.J., Gazaryan, I.G., Bell, G.W., Ginsberg, S.D., and Ratan, R.R.: Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2 independent pathway. Proc. Natl. Acad. Sci. USA, 107: 17385-17390, 2010. PMID: 20855618. PMCID: PMC2951414.
  • Ginsberg, S.D., Alldred, M.J., Counts, S.E., Cataldo, A.M., Neve, R.L., Jiang, Y., Wuu, J., Chao, M.V., Mufson, E.J., Nixon, R.A., and Che, S.: Microarray analysis of hippocampal CA1 neurons implicates  early  endosomal  dysfunction  during Alzheimer’s disease progression. Biol. Psychiatry, 68: 885-893, 2010. PMID: 20655510. PMCID: PMC2965820.
  • Kaur, G., Mohan, P., Pawlik, M., DeRosa, S., Fajiculay, J., Che, S., Grubb, A., Ginsberg, S.D., Nixon, R.A., and Levy, E: Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. Am. J. Pathol., 177: 2256-2267, 2010. PMID: 20889561. PMCID: PMC2966785.
  • Devi, L., Alldred, M.J., Ginsberg, S.D., and Ohno, M.: Sex- and brain region- specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Molecular Brain, 3: 34, 2010. PMID: 21059265. PMCID: PMC2988063.
  • Ginsberg, S.D., Mufson, E.J., Counts, S.E., Wuu, J., Alldred, M.J., Nixon, R.A., and Che, S.: Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer’s disease. J. Alzheimers Dis., 22: 631-639, 2010. PMID: 20847427. PMCID: PMC3031860.
  • Counts, S.E., Perez, S.E., Ginsberg, S.D., and Mufson, E.J.: Neuroprotective role for galanin in Alzheimer’s disease. EXS, 102: 143-162, 2010. PMID: 21299067. PMCID: PMC3117305.
  • Levine, S., Saltzman, A., and Ginsberg, S.D.: Vacuolar pathology in the median eminence of the hypothalamus after hyponatremia. J. Neuropathol. Exp. Neurol., 70: 151-156, 2011. PMID: 21343884. PMCID: PMC3074179.
  • Wintle, R.F., Lionel, A.C., Hu, P., Ginsberg, S.D., Pinto, D., Thiruvahindrapduram, B., Wei, J., Marshall, C.R., Pickett, J., Cook, E.H., and Scherer, S.W.: A genotype resource for postmortem brain samples from the Autism Tissue Program. Autism Res., 4: 89-97, 2011. PMID: 21254448.
  • Ginsberg, S.D., Mufson, E.J., Alldred, M.J., Counts, S.E., Wuu, J., Nixon, R.A., and Che, S.: Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J. Chem. Neuroanat., 42: 102- 110, 2011. PMID: 21669283. PMCID: PMC3163754.
  • Counts, S.E., Che, S., Ginsberg, S.D., and Mufson, E.J.: Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease. J. Chem. Neuroanat., 42: 111-117, 2011. PMID: 21397006. PMCID: PMC3155625.
  • Ginsberg, S.D., Che, S., Hashim, A., Zavadil, J., Cancro, R., Lee, S.H., Petkova, E., Sershen, H.W., and Volavka, J.: Differential regulation of catechol-O- methyltransferase expression in a mouse model of aggression. Brain Struct. Funct., 216: 347-356, 2011. PMID: 21512897. PMCID: PMC3199365.
  • Ginsberg, S.D., Alldred, M.J., and Che, S.: Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease. Neurobiol. Dis., 45: 99-107, 2012. PMID: 21821124. PMCID: PMC3220746.
  • Ginsberg, S.D., Hemby, S.E., and Smiley, J.F.: Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder. Pharmacol. Biochem. Behav., 100: 705-711, 2012. PMID: 22005598. PMCID: PMC3253885.
  • Mufson, E.J., Binder, L., Counts, S.E., DeKosky, S.T., deToledo-Morrell, L., Ginsberg, S.D., Ikonomovic, M., Perez, S.E., and Scheff, S.W.: Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol., 123: 13-30, 2012. PMID: 22101321. PMCID: PMC3282485.
  • Alldred, M.J., Duff, K., and Ginsberg, S.D.: Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol. Dis., 45: 751-762, 2012. PMID: 22079237. PMCID: PMC3259262.
  • Perez, S.E., Getova, D.P., He, B., Counts, S.E., Geula, C., Coutadeur, S., Peillon, H., Desire, L., Ginsberg, S.D., and Mufson, E.J.: Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer’s disease. Am. J. Pathol., 180: 526-540, 2012. PMID: 22142809. PMCID: PMC3349868.
  • Devi, L., Alldred, M.J., Ginsberg, S.D., and Ohno, M.: Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer’s disease. PLoS One, 7: e32792, 2012. PMID: 22403710. PMCID: PMC3293895.
  • Zhang, Y.Q., Henderson, M.X., Colangelo, C.M., Ginsberg, S.D., Bruce, C., Wu, T., and Chandra, S.S.: Identification of CSPα clients reveals a role in dynamin 1 regulation. Neuron, 74: 136-150, 2012. PMID: 22500636. PMCID: PMC3328141.
  • Pillai, A., Bruno, D., Sarreal, A.S., Hernando, R.T., Saint-Louis, L.A., Nierenberg, J., Ginsberg, S.D., Pomara, N., Mehta, P.D., Zetterberg, H., Blennow, K., and Buckley, P.F.: Plasma BDNF levels vary in relation to body weight in females. PLoS One, 7: e39358, 2012. PMID: 22768299. PMCID: PMC3388065.
  • Mufson, E.J., He, B., Nadeem, M., Perez, S.E., Counts, S.E., Leurgans, S., Fritz, J., Lah, J., Ginsberg, S.D., Wuu, J., and Scheff, S.W.: Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer's disease. J. Neuropathol. Exp. Neurol., 71: 1018-1029, 2012. PMID: 23095849. PMCID: PMC3481187.
  • Velazquez, R., Ash, J.A., Powers, B.E., Kelley, C.M., Strawderman, M., Luscher, Z.I., Ginsberg, S.D., Mufson, E.J., and Strupp, B.J.: Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome. Neurobiol. Dis., 58: 92-101, 2013. PMID: 23643842. PMCID: PMC4029409.
  • Kelley, C.M., Powers, B.E., Velazquez, R., Ash, J.A., Ginsberg, S.D., Strupp, B.J., and Mufson, E.J.: Maternal choline supplementation differentially affects the basal forebrain cholinergic system in Ts65Dn and disomic mice. J. Comp. Neurol., 522: 1390- 1410, 2014. PMID: 24178831. PMCID: PMC3959592.
  • Counts, S.E., Alldred, M.J., Che, S., Ginsberg, S.D., and Mufson, E.J.: Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild  cognitive impairment. Neuropharmacology, 79: 172-179, 2014. PMID: 24445080. PMCID: PMC3951099.
  • Kelley, C.M., Powers, B.E., Velazquez, R., Ash, J.A., Ginsberg, S.D., Strupp, B.J., and Mufson, E.J.: Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. Brain Pathol., 24: 33-44, 2014. PMID: 23802663. NIHMSID: 506222.
  • Kaur, K., Sharma, A., Xu, W., Gerum, S., Alldred, M.J., Shivakumar, S., Basavarajappa, B.S., Pawlik, M., Ohno, M., Ginsberg, S.D., Wilson, D.A., Guilfoyle, D.N., and Levy, E.: Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome. J.  Neurosci.,  34:  5099-5106,  2014. PMID: 24719089. PMCID: PMC3983795.
  • Ash, J.A., Velazquez, R., Kelley, C.M., Powers, B.E., Ginsberg, S.D., Mufson, E.J., and Strupp, B.J.: Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice. Neurobiol. Dis., 70: 32-42, 2014. PMID: 24932939. PMCID: PMC4133151.
  • Yan, J., Ginsberg, S.D., Powers, B., Alldred, M.J., Saltzman, A., Strupp, B.J., and Caudill, M.A.: Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult  Ts65Dn trisomic mice. FASEB J., 28: 4312-423, 2014. PMID: 24963152. PMCID: PMC4202107.
  • Alldred, M.J., Lee, S.H., Petkova, E., and Ginsberg, S.D.: Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD). Brain Struct. Funct., Jul 17. [Epub ahead of print]. PMID: 25031177. NIHMSID: 614274.
  • Mariga, A., Zavadil, J., Ginsberg, S.D., and Chao, M.V.: Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function. Dev Neurobiol., Jul 25. doi: 10.1002/dneu.22216. [Epub ahead of print]. PMID: 25059794.
  • Alldred, M.J., Lee, S.H., Petkova, E., and Ginsberg, S.D.: Expression profile analysis of vulnerable CA1 pyramidal neurons in young-middle-aged Ts65Dn  mice.  J Comp Neurol., 523: 61-74, 2015. PMID: 25131634. PMCID: PMC4232465.
  • Ginsberg, S.D., and Che, S.: Methods and compositions for amplification and detection of microRNAs (miRNAs) and noncoding RNAs (ncRNAs) using the signature sequence amplification method (SSAM). Recent Advances in DNA and Gene Sequences, in press.
  • Schafer, M.J., Alldred, M.J., Lee, S.H., Calhoun, M.E., Petkova, E., Mathews, P.M., and Ginsberg, S.D.: Female-specific reduction of β-amyloid and γ-secretase by caloric restriction in Tg2576 mice. Neurobiol. Aging, in press. NIHMSID: 647727.

Submitted Manuscripts:

  • Jiang, Y., Rigoglioso, A., Peterhoff, C.M., Pawlik, M., Sato, Y., Mathews, P.M., Ginsberg, S.D., Levy, E., Lutz, C., Davisson, M.T., Cataldo, A.M., and Nixon, R.A.: Partial BACE1 reduction in a mouse model of Down syndrome blocks Alzheimer- related endosome anomalies and basal forebrain cholinergic neuron degeneration. Submitted for publication.
  • Smiley, J.F., Chao, H.M., Dwork, A.J., Alldred, M.J., Figarsky, K., Rosoklija, G., Mann, J.J., Saltzman, A., Javitt, D.C., and Ginsberg, S.D.: Pyramidal neuron and interneuron selective gene expression changes in schizophrenia cerebral cortex. Submitted for publication.
  • Morales-Corraliza, J., Wong, H., Mazzella, M.J., Che, S., Wagner, J.D., Hemby, S.E., Ginsberg, S.D., and Mathews, P.M: Selective hippocampal increase in Aβ and widespread increase in tau phosphorylation in a primate model of diabetes. Submitted for  publication.
  • Schafer, M.J., Dolgalev, I., Alldred, M.J., Heguy, A., and Ginsberg, S.D.: Calorie restriction suppresses age-dependent hippocampal CA1 transcriptional signatures. Submitted for publication.
  • Arango-Lievano, M., Lambert, W.M., Barrere, C., Wu, S., Bath, K.G., Vos, M., De Vries, C.J.M., Rouillard, C., Levesque, D., Duric, V., Franklin, T.C., Duman, R.S., Lewis, D.A., Ginsberg, S.D., Garabedian, M.J., Chao, M.V., and Jeanneteau, F.: Phosphorylation of glucocorticoid receptors at BDNF-sensitive sites promotes neuronal plasticity to stress. Submitted for publication.
  • Perez, S.E., Hi, B., Nadeem, M., Wuu, J., Ginsberg, S.D., Ikonomovic, M.D., and Mufson, E.J.: Hippocampal endosomal, lysosomal and autophagic dysregulation in mild cognitive impairment: correlation with Aβ and tau pathology. Submitted for publication.
  • Mufson, E.J., Mahady, L., Waters, D., Counts, S.E., DeKosky, S.T., Ginsberg, S.D., Ikonomovic, M.D., Perez, S.E., and Scheff, S.W.: Hippocampal plasticity during the progression of Alzheimer’s disease. Submitted for publication.

Book Chapters and Author’s Notes:

  • Strupp, B.J., Korahais, J., Levitsky, D.A., and Ginsberg, S.D.: Attentional impairment in rats exposed to alcohol prenatally: lack of hypothesized masking by food deprivation. Ann. N.Y. Acad. Sci., 562: 380-382, 1989.
  • Sisodia, S.S., Thinakaran, G., Lamb, B.T., Slunt, H.H., von Koch, C.S., Ginsberg, S.D., Lo, A.C.Y., Lee, M.K., Roskams, A.J.I., Masliah, E., Zheng, H., van der Ploeg, L., Gearhart, J.D., and Price, D.L.: In vivo biology of amyloid precursor protein/amyloid precursor-like proteins and transgenic animal models of Alzheimer's disease. In Turner, J.D., Beyreuther, K., and Theuring, F. (eds): Ernst Schering Foundation Workshop 17. Alzheimer's Disease. Etiological Mechanisms and Therapeutic Possibilities. Berlin: Springer-Verlag, pp. 61-76, 1996. ISBN-13: 978-3-54-060909-4.
  • Ginsberg, S.D., Schmidt, M.L., Crino, P.B., Eberwine, J.H., Lee, V.M-Y., and Trojanowski, J.Q.: Molecular pathology of Alzheimer’s disease and related disorders. In Peters, A., and Morrison, J.H. (eds): Cerebral Cortex, vol. 14. Neurodegenerative and Age-related Changes in Structure and Function of Cerebral Cortex. New York: Kluwer Academic/Plenum, pp. 603-653, 1999. ISBN-13: 978-0-30-645966-5.
  • Van Deerlin, V.M.D., Ginsberg, S.D., Lee, V.M-Y., and Trojanowski, J.Q.: Fixed post mortem brain tissue for mRNA expression analysis in neurodegenerative diseases. In Geschwind, D.H. (ed): DNA Microarrays: The New Frontier in Gene Discovery and Gene Expression Analysis. Washington, D.C.: Society for Neuroscience, pp. 118-128, 2000.
  • Ginsberg, S.D.:  Gene expression profiling using single cell  microdissection combined with cDNA microarrays. In Geschwind, D.H. (ed): DNA Microarrays: The New Frontier in Gene Discovery and Gene Expression Analysis. Washington, D.C.: Society for Neuroscience, pp. 61-70, 2001.
  • Van Deerlin, V.M.D., Ginsberg, S.D., Lee, V.M-Y., and Trojanowski, J.Q.: The use of fixed human post mortem brain tissue to study mRNA expression in neurodegenerative diseases: applications of microdissection and mRNA amplification. In Geschwind, D., and Gregg, J. (eds): DNA Microarrays: Techniques for Neuroscience, Boston: MIT Press, pp. 201-235, 2002. ISBN-13: 978-0-26-207229-8.
  • Ginsberg, S.D.: High quality mRNA purification from paraffin embedded tissues using the KingFisher for molecular fingerprinting. Application Note Number One. ThermoLabsystems, 2002.
  • Ginsberg, S.D.: High quality mRNA extraction with KingFisher for molecular fingerprinting. Focus, 1: 5, 2002.
  • Ginsberg, S.D.: Foreword: Special Issue on Expression Profiling Within the Central Nervous System. Neurochem. Res., 27: 955-956, 2002.
  • Ginsberg, S.D.: Foreword: Special Issue on Expression Profiling Within the Central Nervous System II. Neurochem. Res., 29: 1039-1040, 2004.
  • Ginsberg, S.D., Hemby, S.E., Mufson, E.J., and Martin, L.J.: Cell and tissue microdissection   in   combination   with   genomic   and   proteomic   applications.   In Zaborszky, L., Wouterlood, F.G., and Lanciego, J.L. (eds): Neuroanatomical Tract Tracing 3: Molecules, Neurons, and Systems, New York: Springer, pp. 109-141, 2006. ISBN-13:  978-0-38-728941-0.
  • Che, S., and Ginsberg, S.D.: RNA amplification methodologies. In McNamara, P.A. (ed): Trends in RNA Research, Hauppauge: Nova Science Publishing, pp. 277-301, 2006. ISBN-13: 978-1-59-454506-1.
  • Mufson, E.J., Counts, S.E., Fahnestock, M., and Ginsberg, S.D.: NGF family of neurotrophins and their receptors: early involvement in the progression of Alzheimer’s disease. In Dawbarn, D., and Allen, S.J. (eds): Neurobiology of Alzheimer’s Disease (Molecular and Cellular Neurobiology), Third Edition, Oxford: Oxford University Press, pp. 283-321, 2007. ISBN-13: 978-0-19-856661-8.
  • Ginsberg, S.D.: Expression profile analysis of brain aging. In Riddle, D.R. (ed): Brain Aging: Models, Methods and Mechanisms, New York: CRC Press, pp. 159-185, 2007. ISBN-13: 978-0-84-933818-2. PMID: 21204356.
  • Ginsberg, S.D., Che, S., Counts, S.E., and Mufson, E.J.: Gene expression abnormalities mark the progression of Alzheimer's disease. In Sun, M.K. (ed): Research Progress in Alzheimer's Disease and Dementia, Volume 3, Hauppauge: Nova Science Publishing, pp. 25-58, 2008. ISBN-13: 978-1-60021-960-3.
  • Ginsberg, S.D.: Single and rare cell analysis-amplification methods. T7 based amplification protocols. In Bosio, A. and Gerstmayer, B. (eds): Microarrays in Inflammation. Progress in Inflammation Research, Basel: Birkhäuser-Verlag, pp. 81-94, 2008. ISBN-13: 978-3-7643-8333-6.
  • Ginsberg, S.D.: Single cell gene expression analysis in human postmortem brain tissues and animal models of neurodegeneration. In Konig, S. (ed): Biomacromolecular Mass Spectrometry Research Progress: New York: Nova Science Publishing, pp. 109- 110, 2008. ISBN-13: 978-1-60456-487-7.
  • Mufson, E.J., Counts, S.E., and Ginsberg, S.D.: Cholinergic system. In Squire, L.R. (ed): Encyclopedia of Neuroscience, Volume 2, Oxford: Academic Press, pp. 845- 856, 2009. ISBN-13: 978-0-08-045046-9.
  • Ginsberg, S.D.: Microarray use for the analysis of the CNS. In Squire, L.R. (ed): Encyclopedia of Neuroscience, Volume 5, Oxford: Academic Press, pp. 835-841, 2009. ISBN-13:  978-0-08-045046-9.
  • Ginsberg, S.D.: Gene microarrays. In Kompoliti, K., and Verhagen Metman, L. (eds): Encyclopedia of Movement Disorders. Oxford: Academic Press, pp. 538-540, 2010. ISBN: 978-0-12-374101-1.
  • Mufson, E.J., Counts, S.E., Perez, S.E., and Ginsberg, S.D.: Cholinergic systems in aging and Alzheimer’s disease: neurotrophic and molecular analysis. In Koob, G.F., Le Moal, M., and Thompson, R.F. (eds): Encyclopedia of Behavioral Neuroscience, Volume 1, Oxford: Academic Press, pp. 249-256, 2010. ISBN-13: 978-0-08-044732-2.
  • Ginsberg, S.D., Alldred, M.J., and Che, S.: Gene expression profiling using the terminal continuation (TC) RNA amplification method for small input samples in neuroscience. In Karamanos, Y. (ed): Expression Profiling in Neuroscience, Neuromethods, Volume 64. New York: Humana Press, pp. 21-33, 2012. ISBN-13: 978-1-61779-447-6.
  • Scheff, S.W., Ginsberg, S.D., Counts, S.E., and Mufson, E.J.: Synaptic integrity in mild cognitive impairment and Alzheimer's disease. In Sun, M.K. (ed): Research Progress in Alzheimer's Disease and Dementia, Volume 5, Hauppauge: Nova Science Publishing, pp. 23-49, 2012. ISBN-13: 978-1-61942-192-9.
  • Ginsberg, S.D.: Considerations in the use of microarrays for analysis of the CNS. In Caplan, D. (ed): Reference Module in Biomedical Sciences, Amsterdam: Elsevier, pp. 1-7, 2014. ISBN: 978-0-12-801238-3.
  • Mufson, E.J., Perez, S., Kelley, C.M., Chu, S., Galarza, A., Blakely, S., and Ginsberg, S.D.: Fixation protocols for neurohistology: neurons to genes. In Pelc, R., Doucette, J.R., and Walz, W. (eds): Neurohistology and Imaging: Basic Techniques, Totowa: Humana Press, in press.

Commentaries and Other Publications:

  • Ginsberg, S.D.: Commentary. Tau accused of blocking transport, causing APP to linger and nerve processes to wither. Alzheimer Research Forum. Posted 4/7, 2002.
  • Ginsberg, S.D.: Commentary. Memory-specific temporal profiles of gene expression in the hippocampus. Alzheimer Research Forum. Posted 12/5, 2002.
  • Ginsberg, S.D.: NEWS: Clever Joining of Databases: New Way to Finger Disease Genes. Alzheimer Research Forum. Posted 1/14, 2003.
  • Ginsberg, S.D.: Commentary. Gene expression profiling in Werner syndrome closely resembles that of normal aging. Alzheimer Research Forum. Posted 10/9, 2003.
  • Ginsberg, S.D.: NEWS: New Microarray Data Offer Grist for AD Hypothesizing Mills. Alzheimer Research Forum. Posted 2/9, 2004.
  • Ginsberg, S.D.: NEWS: GLOing Reports from Gene Profiling of Mouse Models. Alzheimer Research Forum. Posted 7/7, 2004.
  • Ginsberg, S.D.: Single-cell RNA analysis to study neuronal populations. Genetic exploration of Alzheimer’s Parkinson’s diseases. New York Academy of Sciences eBriefings. Posted 7/20, 2004.
  • Ginsberg, S.D.: NEWS: Microscopy Shifts to the Fast Lane with "Cytological Profiling". Alzheimer Research Forum. Posted 12/7, 2004.
  • Ginsberg, S.D.: NEWS: Special delivery: NGF Trial Puts Growth Factor Where It’s Needed. Alzheimer Research Forum. Posted 5/3, 2005.
  • Ginsberg, S.D.: NEWS: Ataxia Proteins Tied Together in Disease-related Interactome. Alzheimer Research Forum. Posted 5/28, 2006.
  • Ginsberg, S.D.: Commentary. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Alzheimer Research Forum. Posted 5/1, 2007.
  • Ginsberg, S.D.: Commentary. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Alzheimer Research Forum. Posted 3/12, 2008.
  • Ginsberg, S.D., and Mufson, E.J.: NEWS: AD Clinical Pipeline: Immunotherapy Woes, Dimebon Boons. Alzheimer Research Forum. Posted 8/8, 2008.
  • Ginsberg, S.D.: NEWS: Anne Cataldo, 57, Autophagy Researcher Known for Generous Collegiality. Alzheimer Research Forum. Posted 4/23, 2009.
  • Hedlund, E., Sandberg, R., Chung, C.Y., Karsten, S., and Ginsberg, S.D.: Live Discussion: Microdissection and Microarrays: Analyzing Selective Cell Vulnerability. Alzheimer Research Forum. Posted 9/16, 2010.
  • Ginsberg, S.D.: Commentary. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Alzheimer Research Forum. Posted 12/28, 2010.

Abstracts & Poster Presentations:

  • Bunsey, M., Strupp, B.J., Stasior, J., Levitsky, D.A., and Ginsberg, S.D.: Masking of attentional dysfunction by nutrient restriction. Proc. Soc. Neurosci., 15: 686, 1989.
  • Ginsberg, S.D., Hof, P.R., Young, W.G., Kraemer, G.W., McKinney, W.T., and Morrison, J.H.: Quantitative analysis of transmitter-identified systems in the monkey paraventricular nucleus: effects of differential rearing conditions. Proc. Soc. Neurosci., 17: 895, 1991.
  • Ginsberg, S.D., Siegel, S.J., Hof, P.R., Young, W.G., Kraemer, G.W., McKinney, W.T., and Morrison, J.H.: Effects of social isolation on specific neuronal populations in the primate hypothalamus and hippocampus. Biol. Psychiatry, 31: 196A, 1992.
  • Ginsberg, S.D., Hof, P.R., Young, W.G., and Morrison, J.H.: Quantification of noradrenergic varicosities in apposition to vasopressin-immunoreactive neurons in the monkey paraventricular nucleus. Proc. Soc. Neurosci., 18: 1415, 1992.
  • Ginsberg, S.D., Martin, L.J., Blackstone, C.D., Huganir, R.L., and Price, D.L.: Non-NMDA glutamate receptor (GluR) subtypes in monkey hypothalamus are selectively distributed. Proc. Soc. Neurosci., 19: 918, 1993.
  • Martin, L.J., Blackstone, C.D., Ginsberg, S.D., Huganir, R.L., and Price, D.L.: Non-NMDA  glutamate  receptor  (GluR)  proteins  are  expressed  differentially  in subregions of the hippocampal formation in rat and primate. Proc. Soc. Neurosci., 19: 918, 1993.
  • Ginsberg, S.D., Price, D.L., and Martin, L.J.: Non-NMDA glutamate receptor (GluR) expression following fimbria-fornix (FF) transection. Proc. Soc. Neurosci., 20: 738, 1994.
  • Ginsberg, S.D., Martin, L.J., and Rothstein, J.D.: Regulation of glutamate transporters following selective neural pathway lesions. Ann. Neurol., 38: 308, 1995.
  • von Koch, C.S., Roskams, A-J., Ronnett, G.V., Ginsberg, S.D., Koliatsos, V.E., Price, D.L., Zheng, H., Trumbauer, M., van der Ploeg, L., and Sisodia, S.S.: Analysis of mice with targeted APLP2 and APLP2/APP alleles. Proc. Soc. Neurosci., 21: 259, 1995.
  • Ginsberg, S.D., Portera-Cailliau, C., Price, D.L., and Martin, L.J.: Fimbria-fornix lesions and excitotoxic injury produce similar damage to septal neurons. Proc. Soc. Neurosci., 21: 1584, 1995.
  • Rothstein, J.D., Martin, L.J., and Ginsberg, S.D.: Down regulation of glial glutamate transporters following fimbria-fornix transections and corticostriatal lesions. Proc. Soc. Neurosci., 21: 1862, 1995.
  • Ginsberg, S.D., Crino, P.B., Lee, V.M-Y., Eberwine, J.H., and Trojanowski, J.Q.: Localization of RNA within neurofibrillary tangles and senile plaques in Alzheimer's disease. Proc. Soc. Neurosci., 22: 1174, 1996.
  • Ginsberg, S.D., Crino, P.B., Weingarten, J.A., Lee, V.M-Y., Eberwine, J.H., and Trojanowski, J.Q.: Senile plaques from  Alzheimer's disease brain contain multiple mRNAs. Proc. Soc. Neurosci., 23: 536, 1997.
  • Ginsberg, S.D., Hemby, S.E., Lee, V.M-Y., Eberwine, J.H., and Trojanowski, J.Q.: Single cell mRNA analysis of neurofibrillary tangle bearing CA1 neurons from Alzheimer’s disease brain. Proc. Soc. Neurosci., 24: 962, 1998.
  • Eberwine, J.H., Ginsberg, S.D., Arnold, S.E., Trojanowski, J.Q., and Hemby, S.E.: Gene expression profile of schizophrenia: analysis from individual entorhinal cortical neurons. Proc. Soc. Neurosci., 24: 1274, 1998.
  • Galvin, J.E., Ginsberg, S.D., Lee, V.M-Y., Rorke, L.B., Leight, S., Dickson, D.W., Wolfe, J.H., Jones, M.Z., and Trojanowski, J.Q.: Accumulation of intracellular amyloid- β peptide (Aβ 1-40) in mucopolysaccharidosis brains. J. Neuropathol. Exp. Neurol. 58: 549, 1999.
  • Ginsberg, S.D., Hemby, S.E., Lee, V.M-Y., Eberwine, J.H., and Trojanowski, J.Q.: Expression profile of individual Alzheimer’s disease neurofibrillary  tangle-bearing CA1 neurons using gene microarrays. Proc. Soc. Neurosci., 25: 833, 1999.
  • Ginsberg, S.D., Hemby, S.E., Lee, V.M-Y., Eberwine, J.H., and Trojanowski, J.Q.: Molecular fingerprint of Alzheimer's disease neurofibrillary tangle-bearing hippocampal neurons using cDNA microarrays.. Neurobiol. Aging Suppl., 2000.
  • Mufson, E.J., and Ginsberg, S.D.: Expression profile of cholinergic basal forebrain neurons in mild Alzheimer’s disease using gene microarrays. Proc. Soc. Neurosci., 26: 232, 2000.
  • Lee, C.L., Ginsberg, S.D., and Swann, J.W.: Effects of recurrent early-life seizures in rats on gene expression in the hippocampus revealed by gene microarrays. Proc. Soc. Neurosci., 26: 607, 2000.
  • Ginsberg, S.D.: Expression profile of dentate gyrus granule cells following perforant path lesions in adult mice using gene microarrays. Proc. Soc. Neurosci., 26: 607, 2000.
  • King, S.R., Ishii, T., Ginsberg, S.D., Parker, K.L., Smith, R.G., and Lamb, D.J.: Immunohistochemical Localization of the steroidogenic acute regulatory (StAR) protein in brain. Endocrine Soc. Abstr., 83: 77, 2001.
  • Mufson, E.J., and Ginsberg, S.D.: Single cell and regional cDNA microarray analysis of cholinergic basal forebrain neurons in aged and Alzheimer's disease brain. Proc. Soc. Neurosci., 27: 92.17, 2001.
  • Ginsberg, S.D.: cDNA microarray analysis of mouse dentate gyrus granule cells suggests excitotoxicity as a mechanism of degeneration following perforant path lesions. Proc. Soc. Neurosci., 27: 94.15, 2001.
  • King, S.R., Manna, P.R., Ishii, T., Ginsberg, S.D., Stocco, D.M., Walsh, L.P., Parker, K.L., Smith, R.G., Syapin, P.J., and Lamb, D.J.: Localization and induction of expression of the steroidogenic acute regulatory (StAR) protein in rodent brain. Proc. Soc. Neurosci., 27: 247.1, 2001.
  • Lee, C.L., Armstrong, D., Yoshor, D., Ginsberg, S.D., and Swann, J.W.: Profile of gene expression from microdysgenic cortical neurons in children with intractable seizures. Proc. Soc. Neurosci., 27: 757.1, 2001.
  • Galvan, C.D., Dineley, K.T., Le, J.T., Sweatt, J.D., Ginsberg, S.D., and Swann, J.W: On the mechanisms underlying compensatory changes in hippocampal excitatory synaptic transmission following chronic activity blockade Proc. Soc. Neurosci., 27: 902.14, 2001.
  • Nixon, R.A., Cataldo, A.M., Mathews, P.M., Wegiel, J., Yu, W.H., Keller, J.N., Schmidt, S.D., Jacobsen, S.P., Ginsberg, S.D., Duff, K., Peterhoff, C.M., Terio, N., Mohan, P., and Hassinger, L.: Autophagic cell death: relevance to Alzheimer disease neurodegeneration. Alzheimer's Association International Conference on Alzheimer's Disease (ICAD), 918, 2002.
  • Mufson, E.J., Ginsberg, S.D., Ikonomovic, M.D., and DeKosky, S.T.: Molecular pathology of the cholinotrophic basocortical system in elderly people with mild cognitive impairment. Alzheimer's Association International Conference  on Alzheimer's Disease (ICAD), 1363, 2002.
  • King, S.R., Ginsberg, S.D., Smith, R.G., and Lamb, D.J.: Co-localization of the steroidogenic acute regulatory (StAR) protein, P450scc and MLN-64 in the brain. Endocrine Soc. Abstr., 84: P1-499, 2002.
  • Nixon, R.A., Mathews, P.M., Ginsberg, S.D., Duff, K., Mohan, P., Cataldo, A.M.,  Wegiel, J., Yu, W.H., Schmidt, S.D., Jacobsen, S.P., Peterhoff, C.M., Terio, N., Keller, J.N., and Hassinger, L.: Autophagic cell death: relevance to Alzheimer disease neurodegeneration. Neurobiol. Aging, S415-S416, 2002.
  • King, S.R., Ginsberg, S.D., Ishii, T., Parker, K.L., Smith, R.G., and Lamb, D.J.: Colocalization of the steroidogenic acute regulatory (StAR) protein, with cytochrome P450scc in mouse and human brain. Proc. Soc. Neurosci., 28: 574.17, 2002.
  • Nixon, R.A., Yu, W.H., Cataldo, A.M., Mathews, P.M., Wegiel, J., Schmidt, S.D., Ginsberg, S.D., Peterhoff, C.M., Terio, N., Mohan, P., Hassinger, L., Kumar, A., and Lamb, B.: Autophagy in Alzheimer's disease: autophagy-dependent generation of the amyloid Abeta peptide. Proc. Soc. Neurosci., 28: 2002.
  • Hemby, S.E., Trojanowski, J.Q., and Ginsberg, S.D.: Age related down regulation of dopamine receptor subtype mRNAs in specific neuronal  populations within the human hippocampal formation. Proc. Soc. Neurosci., 28: 686.9, 2002.
  • Mufson, E.J., Counts, S.E., Che, S., and Ginsberg, S.D.: Expression profiles of cytoskeletal mRNAs in cholinergic nucleus basalis neurons in people with mild cognitive impairment and Alzheimer’s disease. Proc. Soc. Neurosci., 28: 686.10, 2002.
  • Elarova, I., Che, S., and Ginsberg, S.D.: Expression profile analysis of hippocampal neurons in Alzheimer's disease and normal aging. Proc. Soc. Neurosci., 28: 686.11, 2002.
  • Che, S., and Ginsberg, S.D.: Amplification of RNA transcripts using terminal continuation (TC) in aging and Alzheimer's disease. Proc. Soc. Neurosci., 28: 686.12, 2002.
  • Ginsberg, S.D.: Single cell cDNA microarray analysis of mouse dentate gyrus granule cells following unilateral perforant path lesions. Proc. Soc. Neurosci.,  28: 686.13, 2002.
  • King, S.R., Ginsberg, S.D., Ishii, T., Parker, K.L., Smith, R.G., and Lamb, D.J.: Colocalization of the steroidogenic acute regulatory (StAR) protein, with cytochrome P450scc in mouse and human brain. Neurobiol. Lipids, 1: M25, 2002.
  • Cai, Y-H., Hicks, J., Ginsberg, S.D., and McClain, K.L.: Gene expression in Langerhans cell histiocytosis. 18th Annual Meeting of the Histiocyte Society, 2002.
  • Geschwind, D., Mirnics, K., Barlow, C., and Ginsberg, S.D.: Microarray: to do or not to do; if so, how to. Winter Conference on Brain Research, 36: 86, 2003.
  • Mufson, E.J., Ginsberg, S.D., and DeKosky, S.T.: Cholinergic plasticity and neurotrophin  signaling  in  people  with  mild  cognitive  impairment:  clues  from  the clergy. 6th International Conference on Alzheimer’s Disease and Parkinson’s Disease (AD/PD 2003), p. 84, 2003.
  • McClain, K., Cai, Y-H., Hicks, J., and Ginsberg, S.D.: Gene expression in Langerhans cell histiocytosis. Pediatr. Res., 53: 288A-289A, 2003.
  • McClain, K.,L., Cai, Y-H., Hicks, J., Peterson, L.E., and Ginsberg, S.D.: Gene expression in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol., 25: A23, 2003.
  • King, S.R., Lamb, D.J., Smith, R.G., and Ginsberg, S.D.: Localization of the steroidogenic acute regulatory (StAR) protein homolog MLN64 in Alzheimer’s disease: a potential link between cholesterol transport and neurodegeneration, Endocrine Soc. Abstr., OR17-5, 2003.
  • Ginsberg, S.D.: Microarray analysis of mouse dentate gyrus granule cells following perforant path transection. Proc. Soc. Neurosci., 29: 841.16, 2003.
  • Elarova, I., Che, S., and Ginsberg, S.D.: Histochemistry, RNA amplification, and cDNA array analysis within the hippocampus. Proc. Soc. Neurosci., 29: 841.17, 2003.
  • Mufson, E.J., Counts, S.E., He, B., Che, S., and Ginsberg, S.D.:  Expression profiles of cholinergic and glutamatergic mRNAs in single cholinergic basal forebrain neurons during the progression of Alzheimer’s disease. Proc. Soc. Neurosci., 29: 841.18, 2003.
  • Che, S., and Ginsberg, S.D.: Expression profile analysis of cerebrospinal fluid (CSF) in Alzheimer’s disease and normal aging. Proc. Soc. Neurosci., 29: 841.19, 2003.
  • Ruben, M.D., Duff, K., Davies, P, and Ginsberg, S.D.: Expression profile of CA1 pyramidal neurons in a mouse model of tauopathy. Proc. Soc. Neurosci., 29: 945.5, 2003.
  • Ginsberg, S.D.: Single cell analysis and RNA amplification in neurodegenerative disorders. Dutch Endo-Neuro-Psycho Meeting, 3: 70, 2004.
  • Ruben, M.D., Duff, K., and Ginsberg, S.D.: Molecular fingerprint of CA1 pyramidal neurons and dentate gyrus granule cells in a murine model of tauopathy. Proc. Soc. Neurosci., 30: 335.3, 2004.
  • Elarova, I., Che, S., Ruben, M.D., Nixon, R.A., and Ginsberg, S.D.: Expression profiling of hippocampal neurons in a mouse model of Down’s syndrome (Ts65Dn). Proc. Soc. Neurosci., 30: 335.4, 2004.
  • Che, S., and Ginsberg, S.D.: Molecular fingerprinting of human cerebrospinal fluid (CSF) using genomic and proteomic platforms. Proc. Soc. Neurosci., 30: 335.5, 2004.
  • Mufson, E.J., Counts, S.E., Che, S., and Ginsberg, S.D.: cDNA array and quantitative PCR analysis of neurotrophin receptor transcripts in cholinergic basal forebrain neurons in people with mild cognitive impairment (MCI) and Alzheimer’s disease. Proc. Soc. Neurosci., 30: 335.6, 2004.
  • Ginsberg, S.D.: Expression profile of mouse dentate gyrus granule cells and dendrites following experimental injury. Proc. Soc. Neurosci., 30: 335.7, 2004.
  • King, S.R., Ginsberg, S.D., and Lamb, D.J.: Expression of the steroidogenic acute regulatory (StAR) protein in steroidogenic cells of the day-old (P1) brain. Proc. Soc. Neurosci., 30: 996.18, 2004.
  • King, S.R., Ginsberg, S.D., and Lamb, D.J.: Expression of the steroidogenic acute regulatory (StAR) protein in steroidogenic cells of the day-old (P1) brain. Neurobiol. Lipids, 3: LL17, 2004.
  • Mufson. E.J., He, B., Perez, S., Counts, S. E, Hohmann, J., Steiner, R., Ginsberg, S.D., and Crawley, J. N.: Galanin gene in the forebrain of people with Alzheimer's disease and transgenic mice. Third International Meeting on Galanin and its Receptors, San Diego, CA., 10/21-10/22, 2004.
  • Ginsberg, S.D.: cDNA array and quantitative PCR analysis of neurotrophin receptor transcripts in cholinergic basal forebrain neurons in people with mild cognitive impairment (MCI) and Alzheimer's disease. Department of Psychiatry Research Day, New York University School of Medicine, P-67, 2005.
  • Ginsberg, S.D.: Expression profiling for genes involved in glutamatergic neurotransmission within the mouse hippocampus following perforant path transections. Proc. Soc. Neurosci., 31: 80.3, 2005.
  • Che, S., and Ginsberg, S.D.: Comparison of human hippocampal CA1 and CA3 pyramidal neuron expression profiles via population cell microarray analysis. Proc. Soc. Neurosci., 31: 80.4, 2005.
  • Elarova, I., Che, S., and Ginsberg, S.D.: Terminal Continuation (TC) RNA amplification coupled with single cell analysis  of neurodegenerative disorders and animal models of neurodegeneration. Proc. Soc. Neurosci., 31: 80.5, 2005.
  • Ruben, M.D., Che, S., Nixon, R.A., and Ginsberg, S.D.: Molecular fingerprinting of hippocampal neurons in a mouse model of Down’s syndrome (Ts65Dn) via microarray analysis. Proc. Soc. Neurosci., 31: 80.6, 2005.
  • Counts, S.E., He, B., Che, S., Ginsberg, S.D., and Mufson, E.J.: cDNA array analysis of galanin-hyperinnervated cholinergic basal forebrain neurons in Alzheimer’s disease. Proc. Soc. Neurosci., 31: 80.12, 2005.
  • Mufson. E.J., Counts, S.E, Che, S., and Ginsberg, S.D.: Shift in the ratio of 3- repeat tau (3Rtau) and 4-repeat tau (4Rtau) mRNA within individual cholinergic basal forebrain neurons during the progression of Alzheimer's disease. Proc. Soc. Neurosci., 31: 208.11, 2005.
  • King, S.R., Smith, A.G.A., Ginsberg, S.D., and Lamb, D.J.: Characterization of the putative cholesterol transport protein MLN64 in the brain. Proc. Soc. Neurosci., 31: 405.4, 2005.
  • King, S.R., Smith, A.G.A., Ginsberg, S.D., and Lamb, D.J.: Characterization of the putative cholesterol transport protein MLN64 in the brain. Neurobiol. Lipids, 4: Published online October 31, 2005.
  • Mufson, E.J., Counts, S.E., and Ginsberg, S.D.: Shifting sands of cholinergic neurotrophic activity in prodromal Alzheimer’s disease. Neurobiol. Aging, 27: S15 Springfield Symposia, Geneva, Switzerland, 2006.
  • Choi, J.H.K, Diaz, N.S., Mazzella, M.J., Peterson, J.N., Cataldo, A.M., Ginsberg, S.D., Levy, E., Nixon, R.A., and Mathews, P.M.: Dysregulation of brain APP in the Ts65Dn Down syndrome mouse. Alzheimers Dement., 2: S236, 2006.
  • Jiang, Y, Mullaney, K.A., Che, S., Schmidt, S.D., Mathews, P.M., Cataldo, A.M., Ginsberg, S.D., and Nixon, R.A.: APP expression modulated AD-related endosomal trafficking abnormalities in Down syndrome fibroblasts. Alzheimers Dement., 2: S250, 2006.
  • Mufson, E.J., Counts, S.E., Che, S., and Ginsberg, S.D.: Cholinergic basal forebrain neurons in people with mild cognitive impairment (MCI) and Alzheimer's disease. Department of Psychiatry Research Day, New York University School of Medicine, P-57, 2006.
  • Choi, J., Diaz, N.S., Mazzella, M.J., Peterson, J.N., Cataldo, A.M., Ginsberg, S.D., Levy, E., Nixon, R.A., and Mathews, P.M.: Dysregulation of brain APP in Ts65Dn Down syndrome mouse model. Department of Psychiatry Research Day, New York University School of Medicine, P-65, 2006.
  • Jiang, Y, Mullaney, K.A., Che, S., Schmidt, S.D., Mathews, P.M., Cataldo, A.M., Ginsberg, S.D., and Nixon, R.A.: Effect of APP/SOD1 inhibition by RNA interference in Down's syndrome fibroblasts. Department of Psychiatry Research Day, New York University School of Medicine, P-66, 2006.
  • Dyakin, V.V., Chen, Y., Ginsberg, S.D., Branch, C.A., Guilfoyle, D.N., Cataldo, A.M, Ardekani, B., Yang, D-S., Peterhoff, C., Peterson, J., and Nixon, R.A.: Quantitative in vivo MR brain imaging in Ts65Dn and Ts1Cje mice: murine model of Down's syndrome. Department of Psychiatry Research Day, New York University School of Medicine, P-67, 2006.
  • Mufson, E.J., Counts, S.E., and Ginsberg, S.D.: Neurotrophic substrate of mild cognitive impairment (MCI) in the elderly: is MCI already Alzheimer's disease. Brain Pathol., 16: S157, 2006.
  • King, S.R., Lamb, D.J., and Ginsberg, S.D.: Localization of the late endosomal protein MLN64 in Alzheimer’s disease: A potential link between cholesterol transport and neurodegeneration. Proc. Soc. Neurosci., 32: 16.11, 2006.
  • Kovacs, K.M., Nixon, R.A., and Ginsberg, S.D.: Microarray analysis of hippocampal pyramidal neurons and dentate gyrus granule cells in a murine model of Down’s syndrome (Ts65Dn). Proc. Soc. Neurosci., 32: 169.1, 2006.
  • Ginsberg, S.D.: Differential regulation of glutamate receptors and transporters following perforant path (PP) transections in adult mice via microarray and qPCR analysis. Proc. Soc. Neurosci., 32: 169.2, 2006.
  • Che, S., Alldred, M.J., Kovacs, K.M., Fang, S., Elarova, I., and Ginsberg, S.D.: Expression profiling using terminal continuation (TC) RNA amplification in human postmortem brain and animal models of neurodegeneration. Proc. Soc. Neurosci., 32: 169.3, 2006.
  • Alldred, M.J., Duff, K., and Ginsberg, S.D.: Expression profiling of hippocampal neurons in hTau mice. Proc. Soc. Neurosci., 32: 169.4, 2006.
  • Mufson, E.J., Che, S., Binder, L.I., Counts, S.E., and Ginsberg, S.D.: Expression profiling of cell survival and downstream signal transduction genes within cholinergic basal forebrain neurons in prodromal Alzheimer's disease. Proc. Soc. Neurosci., 32: 274.1, 2006.
  • Fahnestock, M., Garzon, D., Peng, S., Mount, H.T., Salehi, A., Ginsberg, S.D., Mufson, E.J., Hutter-Paier, B., Windisch, M., and Flood D.G.: Down-regulation  of BDNF mRNA in transgenic mouse models of Alzheimer's disease. Proc. Soc. Neurosci., 32: 271.11, 2006.
  • Sershen, H.W., Che, S., Hashim, A., Cancro, R., Volavka, J., and Ginsberg, S.D.: Regional analysis of catechol-O-methyltransferase (COMT) expression in a mouse model of aggression. Proc. Soc. Neurosci., 32: 287.19, 2006.
  • Nixon, R.A., Cataldo, A.M, Mathews, P.M., Jiang, Y, Ginsberg, S.D., and Peterhoff, C.: Endosome dysfunction in Alzheimer's disease: genetic links and implications for synapse failure and neurodegeneration. Neuropsychopharmacology, 31: S28, 2006.
  • Mufson, E.J., Counts, S.E., and Ginsberg, S.D.: Gene profiling within cholinergic basal forebrain neurons during the progression of Alzheimer’s disease. 8th International Conference on Alzheimer’s Disease and Parkinson’s Disease (AD/PD 2007), Session 5.3, 2007.
  • Peng, S., Garzon, D., Wuu, J., Hutter-Paier, B., Windisch, M., Mount, H.T., Ginsberg, S.D., Mufson, E.J., and Fahnestock,  M.:  Protofibrils  mediate  down- regulation of brain-derived neurotrophic factor in Alzheimer’s  disease  (AD)  and transgenic mouse models of AD. Proc. Soc. Neurosci., 33: 484.13, 2007.
  • Sershen, H.W., Che,  S., Hashim, A., Zavadil, J., Cancro, R.,  Volavka, J., and Ginsberg, S.D.: Differential regulation of  catechol-O-methyltransferase  (COMT) expression in the resident-intruder mouse model of aggression. Proc. Soc. Neurosci., 33: 501.20, 2007.
  • Alldred, M.J., Duff, K., and Ginsberg, S.D.: Microarray analysis of CA1 pyramidal neurons and dentate gyrus granule cells in hTau mice. Proc. Soc. Neurosci. Proc. Soc. Neurosci., 33: 795.14, 2007.
  • Ginsberg, S.D., Che, S., Counts, S.E., Nixon, R.A., and Mufson, E.J.: Microarray analysis of rab gene expression levels within individual cholinergic basal forebrain (CBF) neurons in Alzheimer's disease and mild cognitive impairment. Proc. Soc. Neurosci., 33: 795.15, 2007.
  • Che, S., Alldred, M.J., and Ginsberg, S.D.: Microarray analysis using terminal continuation (TC) RNA amplification in human postmortem brain and animal models of neurodegeneration without second strand synthesis: implications for expression profiling and microRNA (miRNA) amplification. Proc. Soc. Neurosci., 33: 795.16, 2007.
  • Moon, J., Ginsberg, S.D., Gandhy, S., Maclean, K., Ikonomovic, M., Mufson, E.J., and Strupp B.J.: Perinatal choline supplementation reduces cognitive decline and increases cortical choline acetyltransferase activity in the Ts65Dn mouse  model  of Down syndrome & Alzheimer's disease. Proc. Soc. Neurosci., 33: 904.26, 2007.
  • Dyakin, V., Chen, Y., Branch, C., Guilfoyle, D., Ardekani, B., Yang, D., Peterhoff, C., Peterson, J., Ginsberg, S.D., Cataldo, A., and Nixon, R.: In vivo MR identifies cholinergic circuitry deficits in a Down syndrome model. First Annual Department of Child and Adolescent Psychiatry and Department of Psychiatry Research Day, New York University School of Medicine, P-4, 2007.
  • Che, S., Alldred, M.J., Kovacs, K.M., Fang, S., Elarova, I., and Ginsberg, S.D.: Expression profiling using terminal continuation (TC) RNA amplification in human postmortem brain and animal models of neurodegeneration. First Annual Department of Child and Adolescent Psychiatry and Department of Psychiatry Research Day, New York University School of Medicine, P-7, 2007.
  • Jiang, Y., Mullaney, K., Che, S., Schmidt, S., Mathews, P., Cataldo, A., Ginsberg, S.D., and Nixon R.: App gene dosage regulates Alzheimer-related endosome dysfunction in Down syndrome by an Abeta-independent mechanism. First Annual Department of Child and Adolescent Psychiatry and Department of Psychiatry Research Day, New York University School of Medicine, P-9, 2007.
  • Choi, J., Diaz, N., Mazzella, M., Berger, J., Schmidt, S. Cataldo, A., Ginsberg, S.D., Levy, E., Nixon, R., and Mathews, P.: Dysregulation of brain APP in the Ts65Dn Down syndrome mouse. First Annual Department of Child and Adolescent Psychiatry and Department of Psychiatry Research Day, New York University School of Medicine, P-10, 2007.
  • Mufson, E.J., Counts, S.E., Ginsberg, S.D., Perez, S., Elliott-Hunt, C. and Wynick,  D.:  Galanin  in  Alzheimer's  disease.   European   Neuropsychopharmacology 20th ECNP Congress, Vienna, Austria, S207, 2007.
  • Choi, J.H., Mazzella, M.J., Berger, J.D., Cataldo, A.M., Ginsberg, S.D., Levy, E., Nixon, R.A., and Mathews, P.M.: Dysregulation of brain APP in the Ts65Dn Down syndrome mouse. J. Neurochem., 102: 131, 2007.
  • Ginsberg, S.D.: Single cell gene expression analysis in human postmortem brain tissues and animal models of neurodegeneration. Fourth Muenster Conference on Single Cell Analysis, Westfalische Wilhelms University, Muenster, Germany, P6-7, 2007.
  • Mufson, E.J., Counts, S.E., and Ginsberg, S.D.: Neurotrophic changes mark the onset of preclinical Alzheimer's disease: Therapeutic implications. Cell Transplantation, 16: 337-338, 2007.
  • Mufson, E.J., Counts, S.E., and Ginsberg, S.D.: Nerve growth factor receptor dysfunction in early AD. J. Neurochem, 104: 148, 2008.
  • Choi, J.H.K., Diaz, N.S., Mazzella, M.J., Ginsberg, S.D., Levy, E., Nixon, R.A., and Mathews, P.M.: Dysregulation of amyloid precursor protein levels, but not Abeta levels in Ts65Dn mouse brain. Alzheimers Dement., 4: T208-T209, 2008.
  • Che, S., and Ginsberg, S.D.: MicroRNA (miRNA) expression profiling using the miRNA signature sequence amplification (SSAM) technology in human postmortem brain tissues and in animal models of neurodegeneration. Proc. Soc. Neurosci., 34: 46.4, 2008.
  • Alldred, M.J., Duff, K.E., and Ginsberg, S.D.: Expression profile of CA1 pyramidal neurons in aged hTau mice. Proc. Soc. Neurosci., 34: 46.5, 2008.
  • Ginsberg, S.D., Che, S., Counts, S.E., Wuu, J., Nixon, R.A., and Mufson, E.J.: Rab GTPase gene up regulation within individual cholinergic nucleus basalis neurons correlates with cognitive decline in Alzheimer's disease and mild cognitive impairment. Proc. Soc. Neurosci., 34: 46.6, 2008.
  • Counts, S.E., Che, S., Ginsberg, S.D., and Mufson, E.J.: Gender differences in the expression of NGF receptors in single cholinergic nucleus basalis neurons during the progression of Alzheimer’s disease. Proc. Soc. Neurosci., 34: 611.5, 2008.
  • Che, S., Alldred, and Ginsberg, S.D.: Microarray analysis using terminal continuation (TC) RNA amplification in human postmortem brain and animal models of neurodegeneration without second strand synthesis: implications for expression profiling and microRNA (miRNA) amplification. Second Annual Department of Child and Adolescent Psychiatry and Department of Psychiatry Research Day, New York University Langone Medical Center, G-4, 2008.
  • Ginsberg, S.D., Alldred, M.J., Counts, S.E., Cataldo, A.M., Chao, M.V., Wuu, J., Mufson, E.J., Nixon, R.A., and Che, S.: Profiling of CA1 neurons identifies up regulation of select endocytic rab GTPases and concomitant down regulation of neurotrophin receptors during the progression of Alzheimer's disease. Proc. Soc. Neurosci., 35: 325.3, 2009.
  • Elarova, I., Alldred, M.J., Che, S., Counts, S.E., Cataldo, A.M., Neve, R.L., Mufson, E.J., Chao, M.V., Nixon, R.A., and Ginsberg, S.D.: Overexpression of the early endosome effector rab5 in human fibroblasts leads to down regulation of the neurotrophin receptor trkB. Proc. Soc. Neurosci., 35: 325.5, 2009.
  • Che, S., and Ginsberg, S.D.: MicroRNA (miRNA) expression profiling within the frontal cortex of normal aged and Alzheimer’s disease (AD) subjects using the miRNA signature sequence amplification (SSAM) technology. Proc. Soc. Neurosci., 35: 325.6, 2009.
  • Alldred, M.J., Duff, K.E., and Ginsberg, S.D.: Microarray analysis of CA1 pyramidal neurons in aged hTau mice reveals synaptic dysfunction. Proc. Soc. Neurosci., 35: 325.10, 2009.
  • Ginsberg, S.D., Alldred, M.J., Counts, S.E., Cataldo, A.M., Chao, M.V., Wuu, J., Mufson, E.J., Nixon, R.A., and Che, S.: Profiling of CA1 neurons identifies up regulation of select endocytic rab GTPases and concomitant down regulation of neurotrophin receptors during the progression of Alzheimer's disease. New York University Langone Medical Center Neuroscience Retreat, P-13, 2009.
  • Mufson, E.J., Counts, S.E., and Ginsberg, S.D.: The cholinergic system in AD: shifts from survival to death. 11th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy, S-1, 2010.
  • Alldred, M.J., Duff, K.E., and Ginsberg, S.D.: Microarray analysis of CA1 pyramidal neurons in aged hTau mice reveals synaptic dysfunction. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-1, 2010.
  • Che, S., and Ginsberg, S.D.: MicroRNA (miRNA) expression profiling within the frontal cortex of normal aged and Alzheimer’s disease (AD) subjects using the miRNA signature sequence amplification (SSAM) technology. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-2, 2010.
  • Elarova, I., Alldred, M.J., Che, S., Counts, S.E., Cataldo, A.M., Neve, R.L., Mufson, E.J., Chao, M.V., Nixon, R.A., and Ginsberg, S.D.: Overexpression of the early endosome effector rab5 in human fibroblasts leads to down regulation of the neurotrophin receptor  trkB. New York  University Langone Medical Center  of Excellence on Brain Aging Research Day, P-3, 2010.
  • Ginsberg, S.D., Alldred, M.J., Counts, S.E., Cataldo, A.M., Chao, M.V., Wuu, J., Mufson, E.J., Nixon, R.A., and Che, S.: Profiling of CA1 neurons identifies up regulation of select endocytic rab GTPases and concomitant down regulation of neurotrophin receptors during the progression of Alzheimer's disease. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-4, 2010.
  • Dyakin, V.V, Chen, Y., Branch, C.A., Ardekani, B., Yang, D., Guilfoyle, D.N., Peterson, J., Peterhoff, C.M., Ginsberg, S.D., Cataldo, A.M., and Nixon, R.A.: Quantitative in vivo MR brain imaging in Ts65Dn and Ts1Cje mice: murine models of Down's syndrome. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-13, 2010.
  • Choi, J.H.K., Diaz, N.S., Mazzella, M.J., Ginsberg, S.D., Levy, E., Nixon, R.A., and Mathews, P.M.: Dysregulation of amyloid precursor protein levels, but not Aβ levels in Ts65Dn mouse brain: Age-dependent increase in APP expression. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-15, 2010.
  • Jiang, Y., Mullaney, K.A., Peterhoff, C.M., Che, S., Schmidt, S.D., Boyer-Boiteau, A., Ginsberg, S.D., Cataldo, A.M., Mathews, P.M., and Nixon R.A: Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is
  • reversed by BACE-1 inhibition. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-16, 2010.
  • Schafer, M.J., Alldred, M.J., and Ginsberg, S.D.: Caloric restriction regulates SIRT and BDNF pathways in a mouse model of Alzheimer’s disease. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-26, 2010.
  • Scharfman, H.E., Ginsberg, S.D., Ziff E.B., Mathews, P.M., and Chao, M.V.: The entorhinal cortex in Alzheimer’s disease. New York University Langone Medical Center of Excellence Retreat, P-11, 2010.
  • Ginsberg, S.D.: Expression profiling of vulnerable neuronal populations during the progression of AD: lessons from postmortem human brains and relevant animal models of neurodegeneration. Alzheimers Dement., 6: S115, 2010.
  • Choi, J.H.K, Boyer-Boiteau, A., Morales-Corraliza, J., Ginsberg, S.D., Levy, E., and Mathews, P.M.: Dietary fat  and cholesterol causes neuronal  endosomal abnormalities and basal forebrain cholinergic degeneration in wild-type mice. Alzheimers Dement., 6: S188, 2010.
  • Smiley, J.F., Chao, H.M., Dwork, A.J., Alldred, M.J., Elarova, I., Javitt, D.C., and Ginsberg, S.D.: Microarray analysis of subtypes of pyramidal and nonpyramidal neurons from auditory cerebral cortex in schizophrenia. Proc. Soc. Neurosci., 35: 225, 2010.
  • Ginsberg, S.D., Alldred, M.J., Mufson, E.J., Counts, S.E., Wuu, J., Nixon, R.A., and Che, S.: Endosomal and lysosomal genes are selectively dysregulated within CA1 pyramidal neurons in mild cognitive impairment (MCI) and Alzheimer's disease (AD). Proc. Soc. Neurosci., 36: 653.7, 2010.
  • Alldred, M.J., and Ginsberg, S.D.: Microarray analysis of hippocampal pyramidal neurons in murine models of Down’s syndrome (DS) and Alzheimer's disease (AD). Proc. Soc. Neurosci., 36: 653.8, 2010.
  • Counts, S.E., Guillozet-Bongaarts, A.L., He, B, Ginsberg, S.D., Mufson, E.J., and Binder, L.I.: Dysregulation of protein homeostasis genes is associated with early tau conformational changes in nucleus basalis neurons during the progression of Alzheimer’s disease. Proc. Soc. Neurosci., 36: 653.9, 2010.
  • Che, S., Mufson, E.J., Counts, S.E., Alldred, M.J., Wuu, J., Nixon, R.A., and Ginsberg, S.D.: Regional selectivity of rab5 and rab7 protein up regulation in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Proc. Soc. Neurosci., 36: 653.10, 2010.
  • Ginsberg, S.D., Alldred, M.J., Mufson, E.J., Counts, S.E., Wuu, J., Nixon, R.A., and Che, S.: Endosomal and lysosomal genes are selectively dysregulated within CA1 pyramidal neurons in mild cognitive impairment (MCI) and Alzheimer's disease (AD). New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-14, 2011.
  • Alldred, M.J., and Ginsberg, S.D.: Microarray analysis of hippocampal pyramidal neurons in murine models of Down’s syndrome (DS) and Alzheimer's disease (AD). New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-15, 2011.
  • Che, S., Mufson, E.J., Counts, S.E., Alldred, M.J., Wuu, J., Nixon, R.A., and Ginsberg, S.D.: Regional selectivity of rab5 and rab7 protein up regulation in mild cognitive impairment (MCI) and Alzheimer’s disease (AD). New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-16, 2011.
  • Kelley, C.M., Powers, B., Ash, J., Velazquez, R., Strupp, B.J., Ginsberg, S.D., and Mufson, E.J.: Morphological and transcriptome differences in septodiagonal band cholinergic neurons of perinatal choline-supplemented Ts65Dn mice. Rush University Medical Center Research Day, P-1, 2011.
  • Kelley, C.M., Powers, B., Ash, J., Velazquez, R., Strupp, B.J., Ginsberg, S.D., and Mufson, E.J.: Age-related alterations in basal forebrain cholinergic cell populations of the Ts65Dn mouse model for Down syndrome and Alzheimer’s disease. Rush University Medical Center Research Day, P-2, 2011.
  • Mufson, E.J. and Ginsberg, S.D.: Hippocampal neurotrophic signaling and endosomal-lysosomal pathway dysfunction in mild cognitive impairment. Alzheimers Dement.,7:S685,2011.
  • Perez, S.E., Getova, D.P., He, B., Counts, S.E., Coutadeur, S., Peillon, H., Desire, L., Ginsberg, S.D., and Mufson, E.J.: Rac1b, cytoskeletal and cell cycle events within cholinergic basal forebrain (CBF) neurons during the course of AD. Proc. Soc. Neurosci., 37: 48.09, 2011.
  • Kelley, C.M., Powers, B.E, Ash, J.A., Velazquez, Jr., R., Strupp, B.J., Ginsberg, S.D., and Mufson, E.J.: Morphologic and transcriptomic alterations in basal forebrain cholinergic neurons of  maternally  choline-supplemented  segmentally  trisomic (Ts65Dn) mice. Proc. Soc. Neurosci., 37: 152.05, 2011.
  • Ash, J.A., Velazquez, R., Kelley, C.M., Powers, B.E., Strawderman, M., Mufson, E.J., Ginsberg, S.D., and Strupp, B.J.: Perinatal choline supplementation improves spatial learning and increases cholinergic expression within basal forebrain cholinergic neurons (BFCNs) in the Ts65Dn mouse model of Down syndrome. Proc. Soc. Neurosci., 37: 152.06, 2011.
  • Powers, B.E., Kelley, C.M., Ash, J.A., Velazquez, R., Strawderman, M., Mufson, E.J., Ginsberg, S.D., and Strupp, B.J.: Perinatal choline supplementation improves learning of an attention task and alters basal forebrain cholinergic neurons in the Ts65Dn mouse model of Down syndrome. Proc. Soc. Neurosci., 37: 152.07, 2011.
  • Velazquez, R., Kelley, C.M., Powers, B.E., Ash, J.A., Ginsberg, S.D., Strupp, B.J., and Mufson, E.J.: Age-related alterations in basal forebrain cholinergic neuron populations in the Ts65Dn mouse model of Down syndrome and Alzheimer’s disease. Proc. Soc. Neurosci., 37: 152.09, 2011.
  • Smiley, J.F., Chao, H.M., Dwork, A.J., Alldred, M.J., Elarova, I., Javitt, D.C., and Ginsberg, S.D.: Gene expression profile changes within pyramidal neurons and GABAergic interneuron subtypes in schizophrenia cerebral cortex. Proc. Soc. Neurosci., 37: 259.01, 2011.
  • Che, S., Hashim, A., Zavadil, J., Cancro, R., Lee, S.H., Petkova, E., Sershen, H.W., Volavka, J, and Ginsberg, S.D.: Differential regulation of catechol-O- methyltransferase (COMT) gene and protein expression in the resident-intruder mouse model of aggression. Proc. Soc. Neurosci., 37: 266.17, 2011.
  • Alldred, M.J., Duff, K.E., and Ginsberg, S.D.: Microarray analysis of CA1 pyramidal neurons in the hTau mouse model of tauopathy reveals progressive synaptic degeneration. Proc. Soc. Neurosci., 37: 667.01, 2011.
  • Schafer, M.J., and Ginsberg, S.D.: Caloric restriction upregulates neuroprotective pathway gene expression in hippocampal CA1 neurons and may reduce amyloid burden in an Alzheimer’s disease (AD) mouse model. Proc. Soc. Neurosci., 37: 877.11, 2011.
  • Ginsberg, S.D., Mufson, E.J., Alldred, M.J., Counts, S.E., Wuu, J., Nixon, R.A., and Che, S.: Upregulation of select endocytic and exocytic rab GTPases in cholinergic basal forebrain (CBF) neurons in mild cognitive impairment (MCI) and Alzheimer's disease (AD). Proc. Soc. Neurosci., 37: 877.12, 2011.
  • Mariga, A., Ginsberg, S.D., Zavadil, J., and Chao, M.: Transcriptional analysis of rat hippocampal cultures following BDNF withdrawal. Annual Skirball Institute of Biomolecular Medicine Retreat, P-65, 2011.
  • Pomara, N., Bruno, D., Pillai, A., Nierenberg, J.J., Ginsberg, S.D., Mehta, P.D., Zetterberg, H., Blennow, K., and Buckley, P.F.: Circulating Abeta40 negatively influences plasma BDNF levels. Neuropsychopharmacology 36: S91, 2011.
  • Russo, S.J., Ginsberg, S.D., Sadee, W., Maletic-Savatic, M., and Ordway, G.A.: New approaches to probe pathology in the human brain. Winter Brain Conference, 45: 58, 2012.
  • Alldred, M.J., Duff, K.E., and Ginsberg, S.D.: Microarray analysis of CA1 pyramidal neurons in the hTau mouse model of tauopathy reveals progressive synaptic degeneration. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-3, 2012.
  • Che, S., Hashim, A., Zavadil, J., Cancro, R., Lee, S.H., Petkova, E., Sershen, H.W., Volavka, J, and Ginsberg, S.D.: Differential regulation of catechol-O- methyltransferase (COMT) gene and protein expression in the resident-intruder mouse model of aggression. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-4, 2012.
  • Schafer, M.J.,* and Ginsberg, S.D.: Caloric restriction upregulates neuroprotective pathway gene expression in hippocampal CA1 neurons and may reduce amyloid burden in an Alzheimer’s disease (AD) mouse model. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-5, 2012. *Honorable Mention for Best Poster Award.
  • Mariga, A., Ginsberg, S.D., Zavadil, J., and Chao, M.V.: Transcriptional analysis of hippocampal cultures following BDNF withdrawal. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-8, 2012.
  • Pomara, N., Bruno, D., Pillai, A., Nierenberg, J.J., Ginsberg, S.D., Mehta, P.D., Zetterberg, H., Blennow, K., and Buckley, P.F.: Circulating Abeta40 influences plasma BDNF levels. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-32, 2012.
  • Mohan, P.S., Peterhoff, C., Jiang, Y., Mullaney, K., Masliah, E., Michael, S., Che, S., Ginsberg, S.D., and Nixon, R.A: Autophagy gene expression in Alzheimer’s disease brain. New York University Langone Medical Center of Excellence on Brain Aging Research Day, P-34, 2012.
  • Sato, Y., Jiang, Y., Rigoglioso, A., Ginsberg, S.D., Kumar, A., Mohan, P.S., Cuervo, A.M., and Nixon, R.A: Endo-lysosomal and autophagic defects in Down syndrome. New York University Langone Medical Center of Excellence  on  Brain Aging Research Day, P-37, 2012.
  • Velazquez, R.,*# Ash, J.A., Kelly, C., Powers, B.E., Strawderman, M., Mufson, E.J., Ginsberg S.D., and Strupp B.J.: Perinatal choline supplementation improves spatial learning and increases cholinergic neuron density in the medial septal nucleus in the Ts65Dn mouse model of Down syndrome. Neurobehavioral Teratology Society Annual Meeting (NBTS), P08, 2012. *Winner of the James C. Bradford Memorial Student Poster Award. #Winner of the Best Predoctoral Neurobehavioral Teratology Society (NBTS) Presentation Award.
  • Powers, B.E., Kelly, C., Ash, J.A., Velazquez, R., Strawderman, M., Mufson, E.J., Ginsberg S.D., and Strupp B.J.: Perinatal choline supplementation improves learning and attention in Ts65Dn mice and disomic littermates without altering the nucleus basalis cholinergic neuronal phenotype. Neurobehavioral Teratology Society Annual Meeting (NBTS), P09, 2012.
  • Pomara, N., Bruno, D., Pillai, A., Nierenberg, J.J., Ginsberg, S.D., Petkova, E., Sidtis, J.J., Mehta, P.D., Zetterberg, H., Blennow, K., and Buckley, P.F.: Circulating Aβ40 influences plasma BDNF levels and white matter integrity. Alzheimers Dement., 8: P267, 2012.
  • Phelix, C.F., Rahimi, O.B., Colom, L.V., Perry, G. and Ginsberg, S.D.: Transcriptome-to-reactome biosimulation: basal forebrain cholinergic neuron neurotrophin signaling. Alzheimers Dement., 8: P267-P468, 2012.
  • Ginsberg, S.D., Alldred, M.J., Counts, S.E., Wuu, J., Mufson, E.J., and Che, S: Downregulation of select neurotrophin genes in hippocampal CA1 pyramidal neurons and cholinergic basal forebrain (CBF) neurons in mild cognitive impairment (MCI) and Alzheimer's disease (AD). Proc. Soc. Neurosci., 38: 50.01, 2012.
  • Alldred, M.J., and Ginsberg, S.D.: Microarray analysis of hippocampal CA1 pyramidal neurons in a murine model of Down’s syndrome (DS) and Alzheimer’s disease (AD). Proc. Soc. Neurosci., 38: 50.03, 2012.
  • Wu, S.H., Elarova, I., Foll, R., Chao, M.V., Ginsberg, S.D., and Jeanneteau, F.: Neurotrophin signaling pathways are altered in postmortem Alzheimer’s disease (AD) frontal cortex. Proc. Soc. Neurosci., 38, 50.04, 2012.
  • Schafer, M.J., and Ginsberg, S.D.: Caloric restriction and aging modulate hippocampal CA1 pyramidal neuron gene expression in the Tg2576 Alzheimer’s disease (AD) mouse model. Proc. Soc. Neurosci., 38: 50.05, 2012.
  • Che, S., Andreadis, A., Petkova, E., and Ginsberg, S.D.: Analysis of individual 3-repeat tau (3Rtau) and 4-repeat tau (4Rtau) isoforms in postmortem human entorhinal cortex via a qPCR-based assay. Proc. Soc. Neurosci., 38: 50.16, 2012.
  • Velazquez, R., Ash, J.A., Powers, B.E., Kelley, C.M., Strawderman, M., Mufson, E.J., Ginsberg, S.D., and Strupp B.J.: Maternal choline supplementation improves spatial learning and increases adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome. Proc. Soc. Neurosci., 38, 348.02, 2012.
  • Powers, B.E., Ash, J.A., Velazquez, R., Kelley, C.M., Strawderman, M., Alldred, M.J., Ginsberg, S.D., Mufson, E.J., and Strupp B.J.: Maternal choline supplementation improves cognitive function in the Ts65Dn mouse model of Down syndrome: Correlations between basal forebrain cholinergic neurons and performance. Proc. Soc. Neurosci., 38, 348.08, 2012.
  • Fischer-Smith, T, Banerjee, S., Gunnam, S.M., Alldred, M.J, and Ginsberg, S.D.: Altered microglial gene expression in HIV encephalitis, as determined by microarray analysis of laser capture microdissected macrophages/microglia from postmortem human brain. Proc. Soc. Neurosci., 38, 355.15, 2012.
  • Mariga, A., Ginsberg, S.D., Zavadil, J. and Chao, M.V.: Molecular consequences of acute BDNF withdrawal in the hippocampus. Proc. Soc. Neurosci., 38: 442.17, 2012.
  • Budylin, T., Alldred, M.J., Chao, H.M., Balla, A., Elarova, I., Javitt, D.C., and Ginsberg, S.D.: Microarray analysis of cortical parvalbumin interneurons in a mouse model of schizophrenia lacking the NMDAR1 subunit selectively within parvalbumin neurons. Proc. Soc. Neurosci., 38: 662.04, 2012.
  • Lin, Z., Schafer, M.J., Cox, L.M., Yamanishi, S., Ginsberg, S.D., and Blaser, M.J: Effects of long-term caloric restriction on gastric physiology in aged mice. New York University School of Medicine Research Day, New York, NY, P-107, 2012.
  • Schafer, M.J., and Ginsberg, S.D.: Caloric restriction upregulates hippocampal CA1 neuroprotective gene expression and reduces amyloid burden in an Alzheimer's disease mouse model. Clin. Transl. Sci., 5: P199, 2012.
  • Schafer, M.J., and Ginsberg, S.D.: Caloric restriction and aging modulate hippocampal CA1 gene expression in the Tg2576 Alzheimer’s disease mouse model. Keystone Symposia on Molecular and Cellular Biology, Tokyo, Japan. Proceedings of Aging and Diseases of Aging, 3: 80, 2012.
  • Yan, J., Ginsberg, S.D., Powers, B., Alldred, M.J., Saltzman, A., Strupp, B.J., and Caudill, M.A.: Maternal choline supplementation programs offspring choline metabolism in a mouse model of Down syndrome. FASEB J., 27: 111.5, 2013.
  • Che, S., Andreadis, A., Petkova, E., and Ginsberg, S.D.: Analysis of individual 3-repeat tau (3Rtau) and 4-repeat tau (4Rtau) isoforms in postmortem human entorhinal cortex via a qPCR-based assay. NYU Comprehensive Center on Brain Aging Research Day, P-2, 2013.
  • Schafer, M.J.*, and Ginsberg, S.D.: Calorie restriction modulates hippocampal CA1 gene expression and reduces amyloid burden in the Tg2576 Alzheimer's disease mouse model. NYU Comprehensive Center on Brain Aging Research Day, P-3, 2013.
  • Alldred, M.J., and Ginsberg, S.D.: Microarray analysis of hippocampal CA1 pyramidal neurons in a murine model of Down’s syndrome (DS) and Alzheimer’s disease (AD). NYU Comprehensive Center on Brain Aging Research Day, P-4, 2013.
  • Ginsberg, S.D., Alldred, M.J., Counts, S.E., Wuu, J., Mufson, E.J., and Che, S: Downregulation of select neurotrophin genes in hippocampal CA1 pyramidal neurons and cholinergic basal forebrain (CBF) neurons in mild cognitive impairment (MCI) and Alzheimer's disease (AD). NYU Comprehensive Center on Brain Aging Research Day, P-5, 2013.
  • Fischer-Smith, T, Banerjee, S., Gunnam, S.M., Alldred, M.J, and Ginsberg, S.D.: Altered microglial gene expression in HIV encephalitis, as determined by microarray analysis of laser capture microdissected macrophages/microglia from postmortem human brain. NYU Comprehensive Center on Brain Aging Research Day, P-6, 2013.
  • Mariga, A., Ginsberg, S.D., Zavadil, J. and Chao, M.V.: Transcriptional consequences of neurotrophic factor withdrawal from cultured hippocampal neurons. NYU Comprehensive Center on Brain Aging Research Day, P-14, 2013.
  • Devi, L., Alldred, M.J., Ginsberg, S.D., and Ohno, M.: Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer’s disease. NYU Comprehensive Center on Brain Aging Research Day, P-21, 2013.
  • Mariga, A., Ginsberg, S.D., Zavadil, J. and Chao, M.V.: Transcriptional consequences of neurotrophic factor withdrawal from cultured hippocampal neurons. New York University Langone Medical Center Neuroscience Retreat, P-20, 2013.
  • Schafer, M.J., and Ginsberg, S.D.: Caloric restriction modulates CA1 pyramidal neuron gene expression and reduces amyloid burden in an Alzheimer's disease mouse model. Clin. Transl. Sci., 6: P169, 2013.
  • Schafer, M.J., and Ginsberg, S.D.: Caloric restriction modulates CA1 pyramidal neuron gene expression and reduces amyloid burden in an Alzheimer’s disease mouse model. Miami, FL 2013 Winter Symposium: The Molecular Basis of Metabolism and Nutrition, B12, 2013.
  • Kelley, C.M., Powers, B.E., Velazquez, R., Ash, J.A., Ginsberg, S.D., Strupp B.J., and Mufson, E.J.: Impact of perinatal choline supplementation on basal forebrain cholinergic neuron transcriptome and efferents in adult Ts65Dn mice, a model of Down syndrome. Cell Transplantation, 22: 906, 2013.
  • Mariga, A., Ginsberg, S.D., Zavadil, J. and Chao, M.V.: Molecular consequences of acute BDNF withdrawal from cultured hippocampal neurons. Proc. Soc. Neurosci., 39: 130.08/D21, 2013.
  • Schafer, M.J., and Ginsberg, S.D.: Caloric restriction (CR) reduces select secretase complex transcript levels in CA1 hippocampal neurons and attenuates ß- amyloid burden in the Tg2576 Alzheimer’s disease mouse model. Proc. Soc. Neurosci., 39: 134.15/F11, 2013.
  • Mufson, E.J., Perez, S.E., Nadeem, M., Ginsberg, S.D., and Ikonomovic, M.D.: Endosomal-lysosomal regulation in the precuneus and hippocampus in mild cognitive impairment and Alzheimer’s disease. Proc. Soc. Neurosci., 39: 136.06/F45, 2013.
  • Alldred, M.J., Lee, S.H., Petkova, E., and Ginsberg, S.D.: Single population expression profile analysis of hippocampal CA1 pyramidal neurons in an established murine model of Down syndrome (DS) and Alzheimer’s disease (AD). Proc. Soc. Neurosci., 39: 430.21/M12, 2013.
  • Ginsberg, S.D., Jeanneteau, F., Wu, S.H., Fol, R., Elarova, I., Lee, S.H., Petkova, E., and Chao, M.V.: Downregulation of Ankyrin repeat-rich membrane spanning/Kinase D-interacting substrate 220kDa (ARMS/Kidins220)  protein correlates with cognitive decline and neuropathology in the frontal cortex of Alzheimer’s disease (AD) subjects compared to age-matched controls. Proc. Soc. Neurosci., 39: 805.05/F15, 2013.
  • Counts, S.E., Alldred, M.J., Che, S., Ginsberg, S.D., and Mufson, E.J.: Down regulation of pre- and postsynaptic genes within hippocampal CA1 pyramidal neurons in mild cognitive impairment (MCI). Proc. Soc. Neurosci., 39: 805.14/F24, 2013.
  • Mariga, A., Zavadil, J., Ginsberg, S.D., and Chao, M.V.: What happens when you start to lose BDNF. Nerve Growth Factor & Related Neurotrophic Factors: Emerging Concepts, New Mechanisms, Novel Technologies. Cold Spring Harbor Asia/NGF Joint Conference, Suzhou, China, 63, 2014.
  • Arango-Lievano, M., Garabedian, M.J., Ginsberg, S.D., Chao, M.V., and Jeanneteau, F.D.: Characterization of a novel neurotrophic-sensing mechanism of glucocorticoid actions. Proc. Soc. Neurosci., 40: 81.14/LL16, 2014.
  • Schafer, M.J., Dolgalev, I., Heguy, A., and Ginsberg, S.D.: Calorie restriction reverses age-dependent gene expression and induces neuroprotective transcriptional signatures in the hippocampal CA1 region. Proc. Soc. Neurosci., 40: 310.07/J7, 2014.
  • Alldred, M.J., Lee, S.H., Petkova, E., and Ginsberg, S.D.: Effects of maternal choline supplementation (MCS) on CA1 pyramidal neuron gene expression in adult Ts65Dn and normal disomic (2N) offspring. Proc. Soc. Neurosci., 40: 418.05/V21, 2014.
  • Fischer-Smith, T., Ginsberg, S.D., Alldred, M.J, and Gunnam, S.: Altered microglial gene expression suggests impaired microglial function in  HIV  infection, even in the absence of detectable virus in brain. Proc. Soc. Neurosci., 40: 612.04/V10, 2014.
  • Mariga, A., Ginsberg, S.D., Ninan, I., and Chao, M.V.: Withdrawal of BDNF leads to changes in expression of genes involved in synaptic function. Proc. Soc. Neurosci., 40: 689.21/C6, 2014.
  • Cox, L.M., Schafer, M.J., Ginsberg, S.D., and Blaser, M.J.: Calorie restriction, age, and genotype modulate the intestinal microbiota in a mouse model of Alzheimer's disease. Proc. Soc. Neurosci., 40: 788.16/D5, 2014.
  • Ginsberg, S.D., Lee, S.H., Irwin, D.J., Trojanowski, J.Q., Petkova, E., and Che, S.: qPCR analysis of 3-repeat tau (3Rtau) and 4-repeat tau (4Rtau) isoforms in Alzheimer’s disease. Proc. Soc. Neurosci., 40: 788.17/D6, 2014.
  • Counts, S.E., Ginsberg, S.D., and Mufson, E.J.: Locus coeruleus projection system cellular and molecular dysfunction in amnestic mild  cognitive  impairment. Proc. Soc. Neurosci., 40: 793.14/I3, 2014.
  • Schafer, M.J., and Ginsberg, S.D.: Calorie restriction reduced secretase transcript levels in CA1 neurons and attenuates amyloid burden in the Tg2576 Alzheimer’s disease mouse model. 25th Anniversary of the Alzheimer’s Disease Center at New York University Langone Medical Center, P-2, 2014.
  • Alldred, M.J., Lee, S.H., Petkova, E., and Ginsberg, S.D.: Single population expression profile analysis of hippocampal CA1 pyramidal neurons in an established murine model of Down’s syndrome (DS) and Alzheimer’s disease (AD). 25th Anniversary of the Alzheimer’s Disease Center at New York University Langone Medical Center, P-9, 2014.
  • Mariga, A., Zavadil, J., Ginsberg, S.D., and Chao,  M.V.:  Transcriptional profiling in hippocampal neurons following acute BDNF withdrawal  reveals significant changes in synaptic genes. 25th Anniversary of the Alzheimer’s Disease Center at New York University Langone Medical Center, P-25, 2014.
  • Mitchell, R. (Mentor: Ginsberg, S.D.). A Meal to Remember. Science Inventions & Technology S/I/T Exhibition 2014*. North Rockland High School, Thiells, NY. *Winner of a Grade 10-12 award for her presentation from the Rockland County Medical Society.
  • Cox, L.M., Schafer, M.J., Sohn, J., Ginsberg, S.D., and Blaser, M.J.: The microbiota in a murine model of Alzheimer's disease and dietary intervention. Submitted for publication.

Press Coverage:

December 2013 InFocus: NYU Langone Comprehensive Center on Brain Aging, 5: 9, 2013.
November 2013 Newscope, Alzheimer’s Association Newsletter of the Hudson Valley/Rockland/Westchester, NY Chapter, p. 8, Fall, 2013.
November 2013 A Test in Development, Clinical Chemistry, 59: 1680-1682, 2013.
November 2013 InFocus: NYU Langone Comprehensive Center on Brain Aging, 5: 8, 2013.
October 2013 Down Syndrome Pregnancy, October 25, 2013.
September 2013 Cornell Chronicle, September 11, 2013.
Spring 2012 NYU Physician, 63: 25, 2012.
November 2011 Science News: Sanders, L.: Brain gene activity changes through life. 180: 5, 2011.
May 2011 Lancet Neurology
February 2011 Autism Speaks Official Blog
February 2011,May 2011,May 2012,December 2012 NKI Informer
November 2010 Alzheimer Research Forum
September 2010 InFocus: Center of Excellence on Brain Aging June 2010 Alzheimer Research Forum
October 2009 Transformative  Science:  NYU Langone  Medical Center 2009 Research Report.
November 2007 Science: Science Careers
October 2007 Biocompare:  qPCR  For  Lowly  Expressed  Targets  Technology Spotlight.
July 2007  NewYork State Foundation for  Science, Technology, and Innovation (NYSTAR News).
July 2007 Lower Hudson Online (Rockland Journal News).
July 2007 NYU School of  Medicine and Hospitals Center Office of Communications & Public Affairs.
July 2007 NKI Now
August 2006 Alzheimer Research Forum
October 2005 The Scientist
May 2004 New York Academy of Sciences

 

 

 

 

 

 

Autoimmune Journal Flyer